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INTRODUCTION 
Diagnostic imaging is an important part of many diagnostic workups in dogs and cats, 
but does not always allow inflammatory or infectious conditions to be differentiated from 
neoplastic disorders. Cytological or histopathological diagnoses are required for accurate 
diagnosis, prognosis and therapeutic planning (Finn-Bodner and Hathcock, 1993). 
Ultrasound (US)-guided fine-needle aspiration (FNA) and tissue-core biopsy (TCB) 
procedures are routine procedures in small animal medicine that allow precise needle 
placement under real-time monitoring (Hager et al., 1985; Papageorges et al., 1988). 
Collecting biopsies under computed tomography (CT) guidance is indicated mainly for 
thoracic and bone lesions or lesions located in areas difficult to reach with US (Tidwell and 
Johnson, 1994a, 1998, Zekas et al., 2005). Although magnetic resonance imaging (MRI) 
guidance is feasible, the requirement for expensive equipment precludes its widespread use. 
As a consequence, US is the method of choice in daily veterinary practice due to the 
wide availability of US equipment and the lower cost compared to CT, whereas CT is used 
more widely in specialist or referral clinics (Winter et al., 2008). The aim of this study is to 
review the different modalities used for interventional imaging procedures in dogs and cats. 
 
PATIENT PREPARATION AND COMPLICATIONS 
The patient should be evaluated for haemostatic disorders when there is a significant 
risk of bleeding (Nyland et al., 2002a). A basic coagulation profile consists of platelet count, 
haematocrit (determined within 48 hours of biopsy), activated partial thromboplastin time 
(aPTT), one-stage prothrombin time (OSPT) and bleeding time (Bigge et al., 2001; Nyland et 
al., 2002a). 
Fine-needle aspiration can be performed without chemical restraint or local 
anaesthesia, except in cases of poor patient cooperation. For TCB, general anaesthesia is 
required. Animals are positioned to allow easiest access to the lesion, the hair is clipped in the 
area of interest and the site is surgically prepared. 
Studies on abdominal US-guided TCB reported the occurrence of minor complications 
(e.g. mild decrease in haematocrit, minor local bleeding) in 5.6-21.9% of cases and major 
complications requiring intervention (e.g. fluid therapy, blood transfusion) in 1.2-6% of cases. 
Significant bleeding complications were observed in thrombocytopaenic dogs, dogs with a 
prolonged OSPT and cats with prolonged aPTT. In one study, the complication rate was 
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organ-dependent (higher for the kidneys than for the liver) and all major complications 
occurred within 10 hours of biopsy (Bigge et al., 2001). 
 
MATERIALS AND METHODS FOR INTERVENTIONAL PROCEDURES 
The choice between FNA and TCB should be based on the size of the lesion, type of 
tissue to be analysed, information required and institutional access and expertise. Fine-needle 
aspiration is preferred for lesions smaller than 1 cm in diameter, cystic lesions, and highly 
vascular lesions or if diffuse cellular infiltrates are suspected, as in lymphoma or mast cell 
tumour (Nyland et al., 2002a). One study on CT-guidance for lung biopsy reported that the 
value of TCB is limited if the diameter of the lesion is <4 cm. 
 
Fine needle aspiration 
For FNA, 21-25 ga needles are used, mostly injection needles (3 cm long) or spinal 
needles (9 cm long) (Buscarini and Di Stasi, 1993) (Fig. 1).  
 
 
Figure 1: Chiba (Angelo Franceschini) (a), spinal (Artsana) (b) and syringe needles (Troge Medical GMBH) (c) 
are commonly used for aspiration biopsies. (d) Spring loaded semi-automated Tru-cut needle type (Bloodline) 
for tissue-core biopsy. (e) Bone needle with a conical end as in the Jamshidi needle type (Angelo Franceschini). 
 
A sector or linear array transducer, with the highest possible frequency, should be 
used. The most appropriate window and angle for needle insertion should be determined 
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during the initial US or CT examination and the distance between the skin surface and the 
lesion to be sampled should be measured. The use of Doppler US or contrast procedures may 
help to avoid non-viable tissue. 
Fine-needle aspiration can be obtained using the indirect, freehand and guidance 
system techniques; the technique chosen does not influence the quality of samples (Barr, 
1995). For the indirect technique, once US examination has been performed and the lesion has 
been localised, the US transducer is removed and the needle is inserted into the lesion without 
US guidance. A stop can be used to mark the correct needle placement. This technique is 
usually performed to drain fluid from the thoracic or abdominal cavity, to biopsy a large mass 
or for cystocentesis (Nyland et al., 2002a). For the freehand technique, the transducer is 
positioned over the area to be sampled and the needle is aligned with the centre of the US 
beam so that the operator can monitor its passage into the lesion (Menard and Papageorges, 
1995). Visualisation of the needle tip can be improved by moving the needle back and forth 
gently as it is directed toward the target. More experience may be required with this technique 
compared to the guidance system technique, but the freehand technique offers more 
flexibility. For the guidance system technique, a guidance system is attached to the 
transducer. This technique is relatively easy to perform because the angle of the needle is 
fixed and the operator can follow the needle visually along the guidance path (Fig. 2). 
However, maintaining the lesion in the centre of the image is sometimes difficult and the 
rigidity of the system may prevent access to superficial lesions (Nyland et al., 2002a). 
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Figure 2: (A) Transducer with attached guidance system. A spinal needle is inserted into the guidance system. 
(B) Ultrasound-guided sampling using a guidance system biopsy device. The biopsy needle is clearly visible 
within the 2 parallel dotted lines, which represent the pathway determined by the guidance system.  
 
Speed of sampling is important when performing FNA (Kreula, 1990; Kreula et al., 
1990; Tublin et al., 2007). The needle should be inserted as rapidly as possible into the lesion, 
since tissue trauma activates coagulation, which can plug the needle and affect the sample 
quality (Menard and Papageorges, 1995). The biopsy material should be rapidly expelled onto 
glass slides using a syringe previously filled with air and the smears should be made 
immediately to avoid blood clotting. 
The importance of the experience of the observer, needle characteristics, needle 
passes, aspiration, target tissue and presence of a cytopathologist in FNA has been evaluated 
(Fisher et al., 1997a; Winter et al., 2008). The experience of the observer makes no difference 
if a standard protocol is used. A thicker needle is easier to visualise and is less flexible, 
facilitating FNAs, but better samples are obtained with the smaller needles (e.g. 25 ga for 
FNA of the thyroid gland), since these decrease the chance of dilution with blood products 
(Fisher et al., 1997a; Winter et al., 2008). Spinal needles are preferred to standard needles 
because of their shorter bevel. A needle length should be chosen that allows placement into 
the middle of the lesion, plus approximately 5 mm for movement, as a few long passes are 
better than many short passes (Kreula, 1990a; Fisher et al., 1997a; Sheiman et al., 1998). 
The target tissue is also important, since epithelial and round cell tumours will yield 
cells more readily than mesenchymal tumours. A good knowledge of the most common types 
of tumour in different organs and their imaging features allows the most appropriate technique 
to be used. 
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Tissue-core biopsy 
A small skin incision with a No. 11 blade should be made before needle insertion and 
a manual or automated needle type can be used for sampling from soft tissue lesions (Hoppe 
et al., 1986; Parker et al., 1989; Bernardino, 1990; Nyland et al, 2002a). If the biopsy is 
performed with a manual needle, an assistant collects the biopsy, whilst the operator 
maintains the position of the transducer. If an automated needle is used, the operator can 
manipulate the transducer while collecting the biopsy. Spring-loaded needles are most 
frequently used for automated type biopsy guns. Needles with calibrations at 1 cm allow the 
operator to have precise knowledge of the insertion depth, which is useful if the biopsy is not 
taken in real time (i.e. under CT guidance). 
Most Tru-Cut type biopsies are taken with 14 or 18 ga needles. It has been reported 
that using a small needle decreases the risks of complications (Nyland et al., 2002a), but it is 
the authors‘ experience that, with a normal coagulation profile and direct path from the 
transducer to the lesion, better diagnostic samples are obtained with larger needles. If there is 
a need to traverse other organs before reaching the lesion, needles with a smaller diameter are 
preferred (Winter et al., 2008). Bone biopsies are usually performed with a Jamshidi needle. 
 
ULTRASOUND-GUIDED INTERVENTIONAL PROCEDURES 
Ultrasound guidance can assist many interventional procedures, such as FNA, TCB, 
fluid and abscess drainage, catheter placement, delicate centesis and in situ injection of 
pharmaceutical agents (Penninck and Finn-Bodner, 1998). Ultrasound guidance is often safer, 
faster and less expensive and has a higher diagnostic yield than other imaging guidance 
modalities. The presence of air or solid cortical bone between the skin surface and the 
transducer, or within the lesion, can limit the use of US if no appropriate acoustic window can 
be found. 
 
Drainage of cavities and cystic lesions 
Aspiration of fluid can be performed with a venous catheter or by placing a spinal 
needle into the cavity, removing the stylet and aspirating with a syringe. A three-way valve 
with an extension tube is useful for aspirating large amounts of fluid (Penninck and Finn-
Bodner, 1998). Percutaneous drainage of abdominal abscesses can be achieved under US 
guidance and is of value in debilitated patients, since it is less invasive than surgery. 
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Embolisation of prostatic and hepatic abscesses can be achieved safely and rapidly, but 
repeated drainage is sometimes necessary (Boland et al., 2003; Zatelli et al., 2005). Fluid can 
be aspirated from cystic lesions for cytological analysis or to relieve mechanical pressure. 
Ultrasound-guided drainage of true cysts is rarely therapeutic, unless an irritant such as 
ethanol is injected (Penninck and Finn-Bodner, 1998; Zatelli et al., 2007; Agut et al., 2008). 
 
Ultrasound-guided biopsy of abdominal organs 
Liver - Subcostal or intercostal approaches can be used for US-guided biopsy of the liver 
(Finn-Bodner and Hathcock, 1993). Biopsy of diffuse liver disease is routinely performed in 
the left medial or lateral lobe, away from the diaphragm, hilar vessels and gallbladder (Nyland 
et al., 2002a).  
Aspiration of the gallbladder contents is a safe procedure that can be performed for culture of 
bacteria from bile. Aspiration can be performed with a 3.81 cm 18-22 ga needle attached to a 
12 mL syringe via a right ventral abdominal approach into the fundus of the gallbladder. The 
procedure can also be performed for gallbladder decompression in patients with extrahepatic 
biliary obstruction and pancreatitis. The gallbladder should be emptied to reduce bile leakage 
and subsequent peritonitis, although a small amount of bile leakage usually has no 
consequences (Vörös et al., 2002; Savary-Bataille et al., 2003; Beth et al., 2005). A study on 
dogs reported an accuracy of 77% for US-guided TCB of the liver (De Rycke et al., 1999). 
 
Spleen - For US-guided splenic TCB, 16 or 18 ga cutting needles are recommended, whereas 
22 ga needles are recommended for FNA, without suction to decrease blood contamination 
(Finn-Bodner and Hathcock, 1993). In 32 patients with splenic lesions, there was a correlation 
of 61.3% between cytological and histological diagnoses (Ballegeer et al., 2007). Fine-needle 
aspiration and TCB of complex splenic masses (e.g. haemangiosarcoma) are often non-
diagnostic because of blood dilution (Nyland et al., 2002a). 
 
Pancreas - Biopsies of the pancreas can be used to differentiate between pancreatitis, 
pancreatic abscesses, pseudocysts and neoplasia (Bennett et al., 2001; Nyland et al., 2002a). 
Fine-needle aspiration or TCB of the pancreas can be performed safely under US guidance. If 
possible, the passage of the needle through normal pancreatic tissue should be avoided 
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because of the potential complication of acute pancreatitis (Mueller et al., 1988; Nyland et al., 
2002a). 
 
Kidneys – Fine-needle aspiration of the kidneys is frequently performed for diagnosis of 
lymphoma in dogs and cats, while TCB often is required to establish a definitive diagnosis for 
other renal diseases (Vaden et al., 2005). Biopsies of diffuse renal disease should be obtained 
from the cortical area in the pole of the kidney or in a sagittal plane along the lateral cortex, 
avoiding the deep medullary tissue (Finn-Bodner and Hathcock, 1993). The tip of the needle 
should be pointed laterally to avoid the large abdominal vessels. 
Percutaneous pyelography is used to evaluate the size, shape, diameter and patency of the 
renal pelvis and ureters. Pyelocentesis can be performed for bacterial culture, cytology or 
injection of iodinated contrast medium for subsequent radiographic or CT imaging. A spinal 
needle (22-25 ga) is inserted through the renal cortex into the renal pelvis under US guidance. 
Care should be taken to avoid the hilar and interlobar vessels. Urine is removed and, if a 
contrast study is to be performed, the equivalent of one half of the removed volume of 
iodinated contrast agent is slowly introduced. Potential complications include leakage of 
contrast medium, haemorrhage (subcapsular or in the renal pelvis), needle breakage and 
infection (Rivers et al., 1997; Moon, 2009). 
Complications of kidney punctures are reported in 13.4% of dogs and 18.5% of cats (Vaden et 
al., 2005). The most common complication is mild to moderate haemorrhage, while 
hydronephrosis and death are uncommon (Vaden et al., 2005). Renal TCB also poses a risk of 
renal damage, leading to uraemia and hypertension (Léveillé et al., 1993). 
 
Urinary bladder - Percutaneous punctures may be difficult to perform due to the elasticity of 
the bladder. Tumoral seeding after percutaneous US-guided TCB of transitional cell tumours 
has also been described (Nyland et al., 2002b). After a catheter is placed into the urinary 
bladder under US guidance (catheter tip within the lesion), suction with a syringe allows for 
retrieval of a diagnostic sample large enough to perform histological examination (Lamb et 
al., 1996). 
 
Adrenal glands - Image-guided adrenal biopsy has been reported in two dogs with adrenal 
hyperplasia without complications (Besso et al., 1997). Biopsy can be indicated to 
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differentiate between adenomas and adenocarcinomas. Fine-needle aspiration and TCB 
should be avoided if a phaeochromocytoma is suspected because of the risk of hypertensive or 
paradoxical hypotensive crises (Gilson et al., 1994). 
 
Prostate gland - Prostatic samples can be obtained by FNA or TCB. Care should be taken to 
avoid the urethra and the large vessels that lie close to the prostate gland. Mild haematuria 
may present for one or more days after a TCB is taken (Nyland et al., 2002a). 
 
Other indications for US-guided biopsies 
Ultrasound-guided FNA of bone lesions is diagnostic in 75-98% of the cases and may help to 
avoid the need for TCB if conclusive (Samii et al., 1999; Britt et al., 2007). Ultrasound-
guided FNA of the gastrointestinal tract and central or peripheral nervous system has been 
described (Finn-Bodner and Hathcock, 1993; da Costa et al., 2008). 
Ultrasound-guided thoracic interventional procedures are also possible. Since the US beam 
penetrates bone and air poorly, diagnostic ultrasonography of non-cardiac thoracic structures 
is generally limited to evaluation of structures within or adjacent to the thoracic wall using a 
parasternal, intercostal or thoracic inlet imaging window (Reichled and Wisner, 2000). Pleural 
fluid creates an excellent acoustic window, allowing US visualisation of intrathoracic 
anatomy, including pulmonary, chest wall and mediastinal disease not visible radiographically 
(Larson, 2009). 
The US examination can be performed using a 7.5 MHz probe to locate and evaluate the 
pulmonary lesions. For FNA, 22 ga phlebotomy or spinal needles can be used and an 
extension set and 10 mL syringe can be attached to the needle for aspiration (Wood et al., 
1998). In one study, cytology was diagnostic in 51/56 (91%) patients (Reichled and Wisner, 
2000). For TCB, the authors use an automated 14-18 ga needle. 
 
COMPUTER TOMOGRAPHY-GUIDED INTERVENTIONAL PROCEDURES 
Computed tomography guidance is recommended when ultrasonographic lesion visibility or 
accessibility is unsatisfactory (Finn-Bodner and Hathcock, 1993; Tidwell and Johnson, 1994a, 
1998). Computed tomography is particularly indicated for biopsy of bone and thoracic lesions 
and for brain biopsies collected using stereotactic devices (Koblik et al., 1999; Moissonnier et 
Chapter 1.1 : Imaging-guided interventional procedures 
22 
al., 2002; Giroux et al., 2002; Troxel and Vite, 2008). In the future, CT-guidance may also be 
helpful for treatment procedures in veterinary medicine, a feature already used in human 
medicine (Fig. 3). 
 
   
Figure 3: Computed tomographic-guided paranasal tumour ablation treatment with radiofrequency in a dog 
using a soft tissue (A) and a bone (B) window in an adult dog. The radiofrequency probe has been partially 
opened (A) with correct positioning; it can be opened completely (B) and treatment can be started. 
 
A pre- and post-contrast CT examination is performed to confirm the lesion, to assess its 
extent and vascularity and to identify possible metastases. A target plane is chosen at a 
location that shows significant changes so that viable tissue is likely to be sampled. Necrotic 
areas and regions containing large blood vessels should be avoided. 
The CT table is moved to the target plane and the site of insertion of the needle is chosen and 
marked with a sterile radio-opaque metal marker or by inserting a small syringe needle into 
the skin. A few additional CT slices are acquired in the area of the marker to measure the 
distance between the skin and the lesion to be biopsied, as well as to define the insertion angle 
of the needle. The CT table is moved out of the gantry so that the needle and the metallic 
guide or the bone needle (for TCB) can be inserted and advanced to the preset distance and 
angle after a skin incision. The position of the needle tip is evaluated with additional images 
and the needle placement can be corrected if necessary. Additional images in the area of the 
lesion can be taken to check for complications. 
Precise localisation of the needle tip during CT-guided percutaneous biopsy is a key element 
of a successful procedure. Although the low-density artefact has been described as an 
indicator for correct needle tip localisation (Charboneau et al., 1990), this artefact is often 
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associated with a false needle tip. The shape and distinctiveness are more reliable indicators 
of the true needle tip (Tidwell and Johnson, 1994b). 
For TCB of bone lesions, the selected area should provide enough cortical support to hold the 
needle and the complete bone thickness must be sampled to avoid loss of bone material along 
the needle tract (Fig. 4).  
    
Figure 4: Different phases of computed tomographic-guided biopsy of a bone lesion of the distal femur of a 9-
year-old mixed breed dog. A needle is visible going in a wrong direction (A). After correction of the obliquity, a 
bone biopsy needle was inserted and is visible next to the first cortex (B), within the first cortex (C) and after 
passing the second cortex (D). At this time the needle can be retracted. 
 
In one study on CT-guided FNA and TCB of bone lesions in 21 dogs and 2 cats, 17/17 TCB 
(100%) and 5/6 FNA (84.3%) were diagnostic and no major complications were described. 
 For FNA of pulmonary and other intrathoracic lesions, the authors generally use a 21- 
ga spinal needle. Tissue-core biopsies are performed using a 14 ga guide with stylet and 
stopper or a 16 ga spring-loaded automated needle with a 23 mm excursion. A preliminary 
study on CT-guided biopsies of four pulmonary lesions and one cranial mediastinal lesion 
reported that all the samples were diagnostic (Tidwell and Johnson, 1994a). Accuracies of 65-
82% have been reported for FNA and 83-92% for TCB (Vignoli et al., 2004b; Zekas et al., 
2005). Complications include pneumothorax and/or haemorrhage in 32-43% of cases; these 
complications are usually minor and do not require specific treatment (Zekas et al., 2005) 
(Fig. 5). 
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Figure 5: Soft tissue (A,B) and lung (C,D) computed tomography window of the thorax of a 10-year-old mixed 
breed dog with a lung carcinoma and a paraoesophageal abscess. Both mass lesions have a similar pattern, 
although the mediastinal abscess shows a wider hypodense centre. A biopsy needle is inserted into the lung 
lesion (C,D) and purulent material is aspirated from the mediastinal abscess before alcoholisation (= 
percutaneous injection of ethanol) (D).  
 
MAGNETIC RESONANCE IMAGING-GUIDED INTERVENTIONAL PROCEDURES 
The technique for MRI-guided biopsy is similar to that of CT-guided biopsy; however the use 
of expensive, non-ferromagnetic biopsy tools is mandatory, greatly increasing the cost of the 
procedure (Finn-Bodner and Hathcock, 1993). This cost is the main limitation in veterinary 
medicine. 
 
FLUOROSCOPY-GUIDED INTERVENTIONAL PROCEDURES 
Fluoroscopy is rarely used for biopsies, since the equipment is expensive, has limited use, low 
accuracy and inherent radiation danger. With the development of other imaging modalities, 
fluoroscopy is now rarely used for biopsy guidance. Indications for fluoroscopy-guided 
procedures are cardiac catheterisation, serial left-ventricular biopsy, biopsy of pulmonary and 
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other thoracic masses and conservative removal of oesophageal foreign bodies (Suter and 
Lord, 1984; Donker et al., 2007). Fluoroscopy can be useful for guidance of procedures in 
other body areas, such as the pelvis (Fig. 6).  
 
             
 
Figure 6: Computed tomography (CT) fluoroscopy-guided biopsy in a 9-year-old German shepherd dog with 
tenesmus. A pelvic mass compressing the large intestine had been diagnosed on radiography. Computed 
tomography allowed a better delineation of the oval, fluid-filled mass compressing the colon (A) and placement 
of a catheter into the mass (B). Fluoroscopy allowed real-time continuous visualisation of the mass during 
embolisation with ethanol (C). 
 
Successful fluoroscopy-guided percutaneous disc aspiration and discectomy in dogs with 
discospondylitis has been reported (Fisher et al., 1997b; Kinzel et al., 2005), as well as 
fluoroscopic-guided treatment of arthrosis of cervical articular facet joints (Kinzel et al., 
2003). 
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In conclusion, ultrasonography and CT are useful modalities for taking biopsies. With US 
there is real-time control of the needle tip, which decreases the risk of complications. 
Computed tomography is extremely useful if bone or an area surrounded by gas is to be 
sampled. 
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INTRODUCTION  
Ultrasonography (US) is a non-invasive imaging tool that can be used to assess the size, 
shape, parenchymal texture and vascularity of various organs. However, an US image 
provides low contrast, due to the similar acoustic impedances of soft tissues (Cachard et al., 
1997). The accuracy of diagnostic US can be improved by intravenous injection of gas 
microbubbles as vascular contrast agents (Forsberg et al., 1999; Shi et al., 2004). 
Ultrasound contrast agents (USCA) consist of tiny gas-filled microspheres stabilized by an 
outer ‗shell‘. These microbubbles (1-7 m in diameter) are smaller than red blood cells 
eliminating the risk of capillary embolization. Unlike the contrast agents used in computed 
tomography (CT) and magnetic resonance imaging (MRI), USCA are confined to the 
intravascular space which means that after injection they remain in the blood pool and do not 
diffuse in the extracellular space (Calliada et al., 1998; Wilson and Burns, 2001). The gas 
content is gradually eliminated from the blood through the lungs, whereas the stabilizing 
components are filtered by the kidneys and eliminated by the liver (Correas et al., 2001). 
USCA increase the intensity of the echo signal in both gray-scale and Doppler modes by 10 to 
30 dB (10 to 1000 times) during an average of 5 minutes, depending on the contrast agent 
used (Fischer et al., 1998; Droste et al., 2000; Forsberg et al., 2002). The total examination 
duration for a contrast study is about 20 minutes and general anesthesia is not required. 
Contrast-enhanced ultrasonography (CEUS) improves the detection of perfusion and 
vascularity of both normal and abnormal organs. Lesions that have a different perfusion from 
normal tissues will show a specific enhancement after USCA administration. For example, 
regions with segmental infarction will show a signal void representing the absence of vascular 
supply while regions with a high vascularization as malignant tumors will appear as 
hyperechoic areas (Correas et al., 2001; Ziegler and O‘Brien, 2002; Bloch et al., 2004). These 
features also allow to differentiate malignant and benign tumors (Cosgrove, 2003).
 
USCA can 
also be used as blood-pool tracers (functional imaging), in a similar approach as scintigraphic 
tracers,
 
using time-intensity curves (Correas et al., 2001 ; Maresca et al. 1998).
 
During the last decade, several USCA have been developed. In the United States, only three 
USCA are available, approved by The Food and Drug Administration (FDA). These agents 
and their major characteristics are listed in Table 1 (Correas et al., 2001; Albrecht and 
Hohmann, 2004; Robbin et al., 2003). 
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CONDITIONS WHERE CEUS IS WARRANTED 
Only a few recent reports were presented performing CEUS in veterinary medicine. USCA 
were mainly used in the liver (Bahr et al., 2000; Ziegler et al., 2003; O‘Brien et al., 2004; 
O‘Brien, 2007) and the spleen (Ohlerth et al., 2007) in both normal and diseased dogs. 
Furthermore, CEUS was described in clinical circumstances in the kidneys (Taylor et al., 
1996; Bahr et al., 2000; Waller et al., 2007),
 
lymph nodes (Salwei et al., 2005), naturally-
occurring tumors (Scharz et al., 2005) and to visualize portosystemic shunts (Salwei et al. 
2003). 
 
Examination of the liver 
The examination of focal liver lesions is the main indication of CEUS in both dogs and cats. 
The evaluation of focal lesions using conventional, unenhanced US is based on the gray-scale 
morphology (analysis of differences in echogenicity from the surrounding normal liver tissue) 
and Doppler information regarding macrovascular flow (hyper- or hypovascularization) 
(Wilson et al., 2000; Dietrich, 2004; EFSUMB Study Group, 2004). It allows to diagnose 
unambiguously liver cysts (anechogenic content) or calcifications (presence of an acoustic 
shadow) but not always ―soft-tissue‖ liver lesions (Dietrich, 2004). 
Liver nodules are common in dogs as focal hyperplastic nodules are found in up to 70% of the 
dogs older than 6 years and in all dogs older than 14 years (Bergman, 1985). Other causes of 
liver nodules are hematomas, abscesses, focal hepatic necrotic areas, primary neoplasic 
lesions (hepatocellular carcinoma, cholangiocellular carcinoma, carcinoids, sarcoma) and 
metastases of other primary tumors (hemangiosarcoma, islet cell carcinoma, pancreatic 
carcinoma, fibrosarcoma) (Patnaik et al., 1980; Nyland et al., 2002; O‘Brien et al., 2004). US 
liver mass evaluation comprises two essential elements: lesion detection (assessing presence 
and amount of lesions) and lesion characterization (assessing US characteristics, size and 
location). Once a lesion has been detected, lesion characterization can be helpful in the 
differentiation between tumoral and non-tumoral, benign and malignant, or even between the 
different malignant processes, with an accuracy superior to that obtained with cytology. 
(Wilson and Burns, 2001; Cohen et al., 2003 ; Bryant et al., 2004; Dietrich et al., 2004; 
EFSUMB Study Group, 2004; von Herbay et al., 2004; Wang et al., 2004). 
The CEUS pattern of the normal canine liver has been described. As a result of the dual blood 
supply of liver tissue by the hepatic artery (20-30%) and the portal vein (70-80%), three 
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subsequent vascular phases are observed (Brannigan et al., 2004; Dietrich, 2004; EFSUMB 
Study Group, 2004; Nyman et al., 2004). The arterial phase (= enhancement of hepatic 
artery and tributaries) usually starts at 7-10 seconds following injection and lasts 
approximately 10-15 seconds.
 
This is followed by the portal-venous phase (= enhancement 
of portal veins) that can already start approximately 30-45 seconds post injection, lasts until 2 
minutes following injection and, shows a blood flow peak after 15-60 seconds (O‘Brien et al., 
2004; Nyman et al., 2005). The delayed phase (= enhancement of sinusoids throughout liver 
parenchyma) lasts until the USCA has disappeared from the hepatic parenchyma, which may 
take 4-20 minutes depending upon the USCA. (Brannigan et al., 2004; EFSUMB Study 
Group, 2004; von Herbay et al., 2004; Nyman et al., 2004; Oldenburg et al., 2005). 
 
Lesion detection 
CEUS has shown systematically good results for detection of small and ill-defined malignant 
lesions or isoechoic lesions, which are often invisible performing conventional US (Blomley  
et al., 1999; Harvey et al., 2000; Wilson and Burns, 2001; Albrecht and Hohmann, 2004; 
O‘Brien, 2007). Compared with conventional US, additional lesions can be depicted in 40-
45% of patients (Dietrich et al., 2004). CEUS especially improves the detection of metastases 
since these show little or no contrast enhancement (hypoechogenic defects or ―signal voids‖) 
(Fig. 1) (Albrecht and Hohmann, 2004; Brannigan et al., 2004; Dietrich, 2004; EFSUMB 
Study Group, 2004; O‘Brien et al, 2004). 
           
Figure 1: Liver metastases in a dog with pancreatic adenocarcinoma. (A) Conventional US of the liver showing 
multiple unsharply outlined hypoechoic and ‗target lesions‘ (nodules having a hypoechoic rim surrounding an 
isoechoic centre) in the pancreas. (B) Late phase of the CEUS study. The nodules are present as well-defined 
hypoechoic lesions or ‗signal voids‘ indicative for a neoplastic process The diagnosis of pancreatic 
adenocarcinoma was confirmed by histology. 
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This was demonstrated in three dogs with splenic hemangiosarcoma without hepatic lesions 
on conventional US but well-demonstrated nodules on CEUS (O‘Brien, 2007). Most 
hepatocellular carcinomas show a similar appearance on delayed phase imaging as 
metastases, however, some more highly differentiated tumors are isoechoic compared with the 
adjacent liver which makes their detection far more difficult (Albrecht and Hohmann, 2004; 
EFSUMB Study Group, 2004). 
 
Lesion characterization 
The changes in enhancement throughout the different phases contribute to liver lesion 
diagnosis (Albrecht and Hohmann, 2004; Brannigan et al., 2004; Burns and Wilson, 2007). 
The arterial phase gives information on the degree and pattern of vascularity. The portal-
venous and delayed phases provide information about the washout of USCA from the lesion, 
compared with normal liver tissue (Brannigan et al., 2004; Cosgrove, 2003; EFSUMB Study 
Group, 2004)
, 
The majority of benign liver lesions show the typical sustained enhancement 
phenomenon. This means that the lesion shows greater enhancement than the liver during the 
arterial phase and continues to show enhancement equal to or greater than the liver during the 
portal-venous phase. They can be differentiated from most malignant lesions, which show 
early arterial phase enhancement greater than that of the liver and portal-venous/delayed 
phase enhancement less than that of the liver (‗early washin, early washout‘). This happens 
because malignant liver tumors, whether primary or secondary, obtain the majority of their 
blood supply from the hepatic artery (Albrecht and Hohmann, 2004; Brannigan et al., 2004; 
EFSUMB Study Group, 2004; Quaia et al., 2005)
.
 In a study of 32 dogs with spontaneous 
liver nodules, a hypoechoic nodule in the portal and late phase was significantly (P 0.0001) 
correlated with malignancy with very high sensitivity, specificity, positive predictive value, 
negative predictive value and accuracy (100%, 94.1%, 93.8%, 100%, and 96.9%, 
respectively) (O‘Brien et al., 2004). Therefore, CEUS has proven to be a very valuable 
alternative to invasive diagnostic procedures as fine-needle aspiration or core-biopsy. 
 
Examination of the spleen 
Nodular splenic disease is common in dogs and can be caused by non-neoplastic (focal 
nodular hyperplasia, hematoma, infarct, abscess) or neoplastic processes (hemangiosarcoma, 
lymphoma, malignant histiocytosis, other mesenchymal tumors) (Buergelt, 2001). A 
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conventional US examination can distinguish hypo-, hyperechoic and complex focal splenic 
parenchymal abnormalities but cannot help to determine the etiology of the process. 
Moreover, there is a considerable overlap in the US appearance of focal splenic lesions 
(Feeney et al., 1984; Wrigley et al, 1988; Buergelt, 2001) and splenic fine-needle aspirates 
only give a correct diagnosis in 61.3% of the cases (Ballegeer et al., 2007). Splenectomy 
followed by histopathologic examination is therefore often necessary to determine the 
prognosis and therapeutic options (Buergelt, 2001). 
CEUS of the normal spleen (Fig. 2) shows two phases. In the early arterial phase an 
inhomogeneous, patchy enhancement corresponds to the variable flow rates through the cords 
and sinuses of the red pulp and strongly complicates the interpretation of the study (Catalano 
et al. 2005; Harvey et al., 2005; Ohlerth et al., 2007). Therefore, it is recommended to perform 
assessment of the spleen and lesion detection during the delayed phase, at least 60 seconds 
following injection (Harvey et al., 2005; Ohlerth et al., 2007). During the delayed phase, the 
spleen becomes homogeneously enhanced for about 5-7 minutes (Catalano et al. 2005; 
Harvey et al., 2005; Ohlerth et al., 2007). 
 
                                
Figure 2: Arterial and late phase images of a normal canine spleen. (A) The early phase (20 seconds after 
injection) shows an inhomogeneous enhancement (arrows) of the splenic parenchyma followed by subsequent 
homogeneous enhancement starting from approximately 50 seconds (B). Therefore, one should start assessing 
the spleen and its lesions beginning at 60 seconds, to avoid misdiagnosing hypoechoic lesions as being 
malignant. Note the presence of a moderate amount of free abdominal fluid (*). 
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In the canine spleen, Rossi et al. (2008) concluded that CEUS can help in the characterization 
of focal lesions and found that hemangiosarcoma and lymphosarcoma have specific perfusion 
patterns. We used CEUS for improving the visualisation of infarction, the detection of 
(micro)-abscesses, focal nodular lesions, and visualisation of traumatic injuries (Albrecht and 
Hohmann, 2004; Catalano et al., 2005). 
 
Examination of the pancreas 
In veterinary medicine, USCA were only recently used to quantitatively assess the perfusion 
parameters in the normal canine pancreas (Gaschen et al., 2007; Johnson-Neitman, 2007) and 
to detect abnormal perfusion patterns in dogs with pancreatitis (Johnson-Neitman, 2007). 
Significant differences were observed in perfusion parameters between normal dogs and dogs 
with pancreatitis (Johnson-Neitman, 2007).  
In humans, chronic mass-forming pancreatitis and pancreatic carcinoma have the same 
conventional US appearance and clinical symptoms. Using USCA they could be differentiated 
with an overall accuracy of 96% based on their different intralesional ‗parenchymographic 
phase‘ (D‘Onofrio et al., 2006). Due to a massive desmoplastic reaction and low vascular 
density, pancreatic carcinomas remain hypoechoic throughout all phases, unlike the nodules 
in chronic pancreatitis (D‘Onofrio et al., 2006; D‘Onofrio et al, 2007). This phenomenon also 
results in a different contrast-uptake of pancreatic carcinomas and endocrine tumors, as 
insulinomas. Endocrine tumors appear hypervascular, in contrast with carcinomas (Kitano et 
al., 2004; D‘Onofrio et al., 2007; Yang et al., 2007). At our institution, we could distinguish 
an insulinoma from a pancreatic carcinoma using this difference in vascularity. 
  
Examination of the kidneys 
In kidneys of human patients as well as in dogs and rabbits, the use of USCA provides more 
correct morphologic and quantitative information about cortical vascularity (Taylor et al., 
1996; Abildgaard et al., 1997; Cosgrove, 2003). In normal kidneys, CEUS results in early 
enhancement of the renal arteries during the arterial phase, and subsequent homogeneous 
enhancement of the renal cortical parenchyma and the medulla, which becomes isoechoic 
with the cortex (Thorelius, 2004; Waller et al., 2007) (Fig. 3).  
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Figure 3: Enhancement phases of normal kidneys. (A) CEUS results in early enhancement of the renal interlobar 
arteries (arrows) during the arterial phase, (B) with immediate subsequent homogeneous enhancement of the 
renal cortex (approx. 15 s) and, (C) medulla (approx. 30 s), which becomes isoechoic with the cortex. 
 
A recent study by Waller et al. (2007) assessed the normal canine renal perfusion by using 
perflutren lipid microspheres. Maximum enhancement of the renal cortex occurs at 15 
seconds and of the renal medulla at 30 s post-injection (Waller et al., 2007). We used CEUS 
to aid in the diagnosis of renal neoplasia (hemangiosarcoma, metastases) and traumatically 
induced renal hematoma. 
 
Examination of the prostate 
Real-time contrast-enhanced ultrasound has been used to monitor and characterise the normal 
perfusion pattern and perfusion dynamics of the canine prostate gland when using a micro 
bubble contrast agent (Russo et al., 2009) (Fig.4). In all contrast studies, the prostatic artery, 
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entered the prostate gland on the dorso-lateral surface then tunnelled into the prostatic capsule 
and branched into many small parenchymal arteries which were directed medially towards the 
urethra to supply the body of the prostate gland. The flow of the contrast medium into the 
prostatic parenchyma was visible after 15 s. During the wash-in phase, there was an 
homogenous enhancement of the prostatic parenchyma. During the wash-out phase, an 
homogenous decrease of the echogenicity was visible in all cases.L 
 
              
 
               
Figure 4: US images representing the prostate gland in longitudinal section. (A) B-mode US image of a normal 
prostate gland. (B-D) Normal prostate gland using CnTl mode at 3 different times after contrast medium 
administration. (B) At 25 s post-injection, the prostate gland shows homogeneous brightness, due to the filling of 
the gland with contrast medium. The vessel (arrow) dorsal to the prostate is well injected. (C) At 40 s post-
injection, enhancement of the parenchyma is decreased while trabeculae are still enhanced. (D) At 80 sec post-
injection, the prostate gland shows decreased contrast enhancement. The urethra appears as a hypoechoic band 
(Ur) in the 3 images. 
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Examination of the lymph nodes 
Several changes evaluated by US can help in discriminating normal and abnormal 
(inflammation, lymphoma or metastatic neoplasia) lymph nodes. The combination of the 
lymph node size, distribution of vascular flow and the pulsatility index was found to be the 
most accurate to differentiate between these four categories with a classification error of only 
23%. When only two groups (benign, malignant) were used, this error was reduced to 11% 
(Nyman et al., 2005). 
Measurement of blood flow using Doppler modalities is possible in just over half of the 
normal nodes and in slightly more than 80% of reactive and malignant nodes, which is caused 
by a lack of detector sensitivity (Nyman et al., 2005). In humans, signal enhancement using 
USCA remarkably improved this sensitivity and provided better conspicuity of the vessel 
morphology in all lymph nodes, 2.13 times more vessels could be seen using CEUS compared 
with power Doppler US (P 0.01) (Schroeder et al. 1999). 
Using perflutren lipid microspheres
f
, the aspect of peripheral lymph nodes in 11 dogs with 
lymphoma could be characterized: 45.5% of the nodes had displacement of the central hilar 
vessels, 45.5% had aberrant vessels, 63.6% had pericapsular vessels, 36.4% had subcapsular 
vessels and 81.8% had loss of the ―hilus sign‖ (Salwei et al., 2005).  
In staging of cancer patients, the finding of lymph node metastases is an important prognostic 
determinant and a key in the therapeutic choice. The sentinel lymph node is defined as the 
first node to receive lymphatic drainage from a neoplasia. Currently, Technetium-99m 
scintigraphy or a blue dye injection into or near a tumor are used to detect a sentinel lymph 
node (Wisner et al., 2003; Goldberg). In dogs, following subcutaneous injection of an USCA, 
microbubbles were able to show contrast enhancement in 85% of the sentinel lymph node. 
When using smaller bubbles, this was increased to 94% (Wisner et al., 2003).
 
It has to be 
emphasized that the previous findings are related to superficial lymph nodes. Further studies 
are needed to assess the behaviour of USCA in abdominal lymph nodes. 
 
Vascular application 
Initial clinical results indicate that dogs with congenital extrahepatic portosystemic shunts 
have shorter times to peak perfusion in the liver (7.0 ± 2.0 seconds) than normal dogs (22.8 ± 
6.8 seconds), which is indicative for increased hepatic arterial blood flow (Salwei et al., 
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2003). However, to make a valid diagnosis, this finding has to go together with an increased 
size and tortuosity of the hepatic arteries (Salwei et al., 2003).
 
 
QUANTIFICATION OF USCA – TIME INTENSITY CURVES 
Quantification of USCA is of fundamental importance as it allows to objectively evaluate 
tissue perfusion. It also permits the detection of diffuse tissue changes (Schmid and Lang, 
1995; Maresca et al., 1998; Maruyama et al., 2005). USCA can be used as tracer for dynamic 
studies of organs such as the liver, kidney or brain. The arterio-venous transit time of USCA 
can be digitally processed and the resulting time-intensity curves allow measurement of the 
rate of uptake and/or clearance of contrast in a specific location (Schmid and Lang, 1995; 
Albrecht and Hohmann, 2004) 
In the past few years, several high-end US systems have been developed which carry a built-
in software package that generates time-intensity curves (Blomley et al., 1998; Maresca et al., 
1998; Lefèvre et al., 2002; Maruyama et al., 2005). It can be used directly during real-time 
imaging and results in a reduction in errors compared to extern software because there is a 
decreased amount of passages between different machines. Furthermore, there is a 
standardization of the measurement system (Maresca et al., 1998). Using these software 
systems, regions of interest (ROIs) can be placed in vessels and/or adjacent parenchyma 
(Lefèvre et al., 2002; Caruso et al., 2005; Maruyama et al., 2005; Okada et al., 2005). For 
each ROI, the gray-scale or Doppler signal changes are calculated during a certain duration of 
time and displayed as a time-intensity curve (Caruso et al., 2005; Maruyama et al., 2005; 
Okada et al., 2005). Mathematical analysis of these curves yields quantitative hemodynamic 
indices relating to blood flow in either tissue volumes or within individual vessels (Schwarz et 
al., 1996; Bang et al., 2001 ; Correas et al., 2001; Krix et al., 2003; Caruso et al., 2005; 
Maruyama et al., 2005; Okada et al., 2005). 
After intravenous bolus injections of USCA, time-intensity curves have a characteristic 
dilution shape consisting of a two phase dose-response (Schwarz et al., 1996; Lefèvre et al. 
2002). The first phase shows a quick rise in intensity followed by a fast linear decrease during 
the early washout phase. The phase 1 kinetics corresponds to the first pass of contrast through 
the arterial circulation followed by the distribution of USCA. It depends on the dose of 
contrast administered, the cardiac output and the size of the ROI (Schwarz et al. 1996; Ordén 
et al., 2003). The second phase represents a slow linear decrease of the washout phase. It is 
the predominant effect observed after intravenous injection in terms of duration. The kinetics 
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of phase 2 represents the recirculation of contrast between the arterial and venous circulation. 
They depend on the elimination of the contrast from the blood pool, the dose administered 
and the size of the ROI, but not on the cardiac output. The first phase is much shorter than the 
second phase (Schwarz et al. 1996; Ordén et al., 2003). On infusion sequences, the curves 
show a progressive enhancement with a plateau-like enhancement profile that lasts until the 
end of the infusion (Fig. 5). (Lefèvre et al. 2002; Okada et al., 2005).  
 
 
Figure 5: Bolus versus infusion. (A) After injection of a contrast bolus, a typical washin-washout curve is 
obtained. There is a two-phase dose response: a sharp rise in intensity is followed by a more gradual decrease 
during the washout phase. (B) Infusion curves show a progressive enhancement with a subsequent plateau, 
which lasts until the end of the infusion. 
 
Changes in vascularity and blood flow seen secondary to pathology are represented in the 
time-intensity curve as alterations of its shape (Maresca et al., 1998; Maruyama et al 2005).
 
Time-intensity perfusion curves have been generated in the liver (Ziegler et al., 2003; Nyman 
et al. 2005), spleen (Ohlerth et al. 2007) and kidneys (Waller et al., 2007)
 
of normal dogs. 
Nyman et al. (2005) demonstrated an influence of the anesthetic protocol on the perfusion 
indices from time-intensity curves of the normal canine liver.
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 Of all current imaging modalities, ultrasonography (US) is the most commonly used in 
veterinary diagnostic imaging for biopsy guidance, mainly of abdominal lesions. US-guided 
fine-needle aspiration (FNA) has been described for diagnosis of bone lesions with a 
diagnostic accuracy of 75-98%, and therefore it may help to avoid tissue-core biopsy (TCB) 
in a majority of cases (Samii et al., 1999; Britt et al., 2007). However, the diagnostic accuracy 
of US for guidance is not always satisfactory. In a study on US-guided liver TCB in dogs, a 
diagnostic accuracy of 77% was obtained (De Rycke et al., 1999). Complications of US-
guided TCB have also been reported, the most common one being a moderate hemorrhage 
(Vaden et al., 2005). A rarely described complication is tumoral seeding of neoplastic cells 
along the biopsy needle tract (Nyland et al., 2002).  
 There are few reports describing the use of computed tomography (CT) for biopsy 
guidance in veterinary medicine (Finn-Bodner and Hathcock, 1993; Tidwell and Johnson, 
1994; Daniel and Mitchell, 1999; Henninger, 2003; Zekas and Crawford, 2004). However, CT 
has potential advantages for biopsy guidance compared to US such as the possibility to biopsy 
bone and lesions surrounded by gas. 
 Contrast-enhanced ultrasound (CEUS) has becoming more available and is considered 
a useful modality for diagnosis of focal abdominal lesions (O‘Brien et al., 2004; Rossi et al., 
2008; Haers and Saunders, 2009 ).  
The aim of the present study was to describe methods that can be used to improve 
imaging diagnosis either invasively (imaging-guided biopsies), or non-invasively (contrast 
enhanced ultrasonography). The feasibility of the procedure, its diagnostic accuracy* and the 
complication rate were evaluated. 
Therefore specific studies were performed on different anatomical regions/systems (axial and 
appendicular skelet, lungs, abdominal organs). The aims of these study were: 
1) to assess the accuracy of percutaneous freehand CT-guided biopsy in the diagnosis  
of bone disorders in dog and cat. 
2) to assess the accuracy of percutaneous freehand CT-guided biopsy in the diagnosis of 
lung disorders in dogs and cats. 
3) to evaluate a manual biopsy device (―Spirotome‖) for quality of histological sampling 
obtained with US-guidance of the liver, spleen and kidney in canine cadavers and in a 
clinical trial in dog and cat. 
4) to report complications of abdominal US-guided biopsy procedures.  
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5) to describe the use of CEUS in dogs with prostatic disease, and to evaluate the 
perfusion kinetics in dogs with a normal prostate and those with prostatic disease. 
 
 
 Diagnostic accuracy was defined as: 
 
number of true positives + true negatives 
_____________________________________________________________ 
 
number of true positives + false positives + false negatives + true negatives 
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SUMMARY 
 
 In humans, freehand computed-tomography (CT)-guided biopsy is an accurate 
method to obtain a tissue sample. There are only a few reports of this technique in 
veterinary medicine.  
 In the present study, 21 dogs and 2 cats underwent a freehand CT-guided tissue-
core biopsy (17 animals) or fine needle aspiration (6 animals) of a bone lesion. Two out 
of 17 tissue core samples were also cultured. All 17 tissue-core biopsy samples were 
diagnostic (accuracy of 100%). Five out of 6 aspirates were diagnostic (accuracy of 
83.3%). The overall accuracy was 95.7%. In one aspirate, cytologic quality was 
insufficient containing only blood. No major complications were encountered. Fourteen 
neoplastic, 2 infectious and 6 benign lesions were diagnosed. Computed tomographic 
examination after intravenous contrast medium added useful information to avoid large 
vessels and to biopsy viable tissue.  
 Freehand CT-guided tissue-core biopsy and fine-needle aspiration appear to be 
safe and very accurate procedures for use in the diagnosis of bone-associated diseases in 
small animals. 
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INTRODUCTION 
 
 Definitive diagnosis of a bone lesion depends on histopathologic evaluation. Tissue-
core biopsy (TCB) is the most common procedure performed. With percutaneous blind 
biopsies of bone lesions, samples are frequently non-diagnostic because of failure to select a 
suitable sample site (Withrow and Lowes, 1981; Withrow, 1991; Finn-Bodner and Hathcock, 
1993). In contrast, guidance of biopsies increases accuracy (Finn-Bodner and Hathcock, 
1993).  
 Fine-needle aspiration (FNA) of bone lesions and related soft tissues under ultrasound 
(US) guidance as well as fluoroscopic-guided biopsy has been described (Finn-Bodner and 
Hathcock, 1993; Bender, 1986; Gil-Sanchez et al., 2001). However, accuracy was only 
moderate. Another advantage of US is the use of Doppler sonography to select vascularized 
areas of viable tumor (Finn-Bodner and Hathcock, 1993).  
In humans, computed tomography (CT) is frequently used for biopsy guidance (Hardy 
et al., 1980; Adapon et al., 1981; McGahan and Dublin, 1985; Bender, 1986; Frager et al., 
1987; Welch et al., 1989; Settle et al., 1990; Brugieres et al., 1991; Brandt et al., 1993; 
Bernardi and Castellan, 1995; Lucidarne et al., 1998; Kang et al., 1999; Meneghello et al., 
1999; Sans et al., 1999; Trambert, 1999; Yao et al., 1999; Duda et al., 2001; Hänninen et al., 
2001; Rimondi et al., 2001). Computed tomography-guided biopsy has been recommended 
for use in humans when lesion visibility or accessibility by other imaging modalities is 
unsatisfactory (Tidwell and Johnson, 1994).  
 Description for application of CT-guided biopsies in animals is limited (Finn-Bodner 
and Hathcock, 1993; Tidwell and Johnson, 1994; Daniel and Mitchell, 1999), and there is 
only one report regarding the number of biopsies, biopsy location and histopathologic results 
(Tidwell and Johnson, 1991). Correct diagnosis was obtained in 12 out of 15 biopsies.  
 The purpose of this paper was to describe a percutaneous freehand CT-guided biopsy 
technique, and to assess its accuracy in the diagnosis of bone lesions in small animals. 
 
MATERIALS AND METHODS 
 
 From April 2001 to April 2002, 21 dogs of various breed, size and sex and 2 shorthair 
cats underwent freehand CT-guided bone TCB or FNA. All patients had radiographically 
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primary bone lesions or secondary bone involvement from a soft tissue lesion. The bone 
lesion was examined radiographically in every patient. However, full extent and exact 
location of the lesions were difficult to assess and the final radiographic diagnosis was often 
inconclusive. Consequently, animals underwent CT for better assessment of the lesion and for 
freehand CT-guided TCB or FNA. A 70 mm long, 22 ga spinal needle
*
, and a 100 mm long, 
12 ga calibrated bone biopsy needle
§
, were used for FNA and TCB, respectively. The non-
automatic calibrated bone biopsy needle consists of an outer cutting cannula, together with an 
internal obturator, which was inserted and advanced manually to the proximal margin of the 
lesion. Then, the internal obturator was removed and only the cannula was advanced through 
the lesion. A new needle was used in every animal.  
 The CT examinations were carried out with a spiral CT in Bologna , Italy and a 3
rd
 
generation CT in Zurich , Switzerland and in Rome , Italy. General anaesthesia was induced 
intravenously with Propofol  at a dose of 8 mg/kg. After endotracheal intubation, anesthesia 
was maintained with isoflurane  delivered in oxygen. Animals were positioned in a way 
allowing easy access to the lesion and clipped in the area of interest with subsequent surgical 
preparation. Standard image acquisition of the area of interest was performed. Slice thickness 
was always 3 mm with 2 mm table feed. In 16 animals, regions of interest were rescanned 
after an intravenous bolus injection of iodinated contrast medium
**
 at a dose of 800 mg/kg, to 
assess the vascularity of the lesion and the surrounding soft tissue structures. After the CT 
study was completed, acquisition was paused to allow assessment of the location and extent 
of the lesion and the selection of the target plane. The target plane was chosen in an area with 
significant changes so that viable tissue samples were likely to get, but which also provided 
enough cortical support to hold the needle. Areas suspicious of necrosis and large vessels 
were avoided. Then, the CT table was moved to the target plane, which was indicated by the 
laser light in the gantry. In this plane, the site for insertion of the needle was subjectively 
chosen and marked with a sterile radiopaque metal marker. Subsequently, a few additional 
slices in the area of the marker were acquired to measure the distance between the skin and 
the end of the bone lesion as well as the insertion angle (Fig. 1).  
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Figure 1: A metallic marker is positioned on the skin of a dog. Measurement between the skin and the distal 
margin of the radius to be biopsied is shown. 
 
 
 
 The CT table was moved out of the gantry so that the needle could be placed and 
advanced the preset distance and angle after a skin incision. The position of the needle tip was 
evaluated with additional images and correction of needle placement was performed when 
indicated before the lesion was sampled. To avoid loss of the bone biopsy sample along the 
needle tract and to increase the percentage of positive results, the total bone thickness was 
sampled with the calibrated bone needle (Fig. 2, 3).  
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Figure 2: Osteosarcoma of the right tibia in a 7-year-old Doberman: On the radiographic images (A and B) there 
is a poorly defined aggressive lesion of the proximal metaphysis with multiple lytic areas involving the 
medullary bone and the lateral cortex. On the CT images (C and D), the lesion was well delineated and marked 
cortical and medullary bone lysis, new bone formation and soft tissue mineralization was seen. Note the needle 
in two different phases of the biopsy. In (C), the needle is placed slightly oblique in the soft tissues and streak 
artifacts are visible due to the high-density material (needle) that reduces the transmission of x-rays. In (D), the 
biopsy needle is visible through the entire bone lesion is visible. The abrupt end of the needle and the low-
density artifact distal to the needle are consistent with the true tip of the needle. 
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Further, suction with a syringe was also applied during retraction of either needle type. 
Only a single specimen was taken in each lesion. Immediately after recovery from anesthesia 
and during the following days, animals were monitored for complications. 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Post-contrast CT image (A) and different phases of the biopsy procedure (B and C) of the right nasal 
cavity in a 10-year-old English Setter. Final diagnosis was undifferentiated carcinoma. 
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RESULTS 
 Biopsies of 21 dogs and 2 cats were included in the study. 
Table 1: CT-procedure and results in 21 dogs and 2 cats with bone-associated lesions 
Signalement: breed, age 
(years), sex (M-F) 
Biopsy 
technique 
Organ     
involved 
Histological/Cytological 
diagnosis 
Outcome 
English Setter, 10, F   TCB Nasal cavity Undifferentiated carcinoma 12m survival after RT 
Dalmatian, 7, M TCB Spine Osteomyelitis (Staphylococcus)  Healed 
Mix, 8, F TCB Zygomatic bones Adenocarcinoma 3m local control RF 
Dobermann, 9, F TCB Pelvis Osteoporosis Lost for follow-up 
lollow- 
 
 
 
 
upupupImproved 
lameness 
Argentine Dogo, 7, F TCB Spine (meta‘s) Mammary adenocarcinoma Euthanasia 
Boxer, 2, M TCB Radial carpal bone Non-union/fatigue fracture* Improved lameness 
after arthrodesis 
Labrador Retriever, 8, M TCB Nasal cavity Undifferentiated carcinoma Euthanasia 
Doberman, 7, M TCB Tibia Osteosarcoma Euthanasia 
Bracco Italiano, 2, M TCB Radius Osteosarcoma Lost 
Pastore Maremmano, 7, F TCB Femur Osteosarcoma Euthanasia 
Mix, 7, F TCB Femur Traumatic inflammatory 
periostitis (culture: negative) 
Healed 
Boxer, 1.5, F TCB Femur Dysplasia epiphysealis 
hemimelica 
Severe artrosis 
English Setter, 11, M  TCB Spine Fibrosarcoma Euthanasia 
Westie, 12, M TCB Zygomatic bones Adenocarcinoma Euthanasia 
Mix, 2.5, F TCB Radius Osteosarcoma Lost 
Mix, 7, M TCB Radius Traumatic inflammatory 
periostitis  
Lost 
Mix, 2, F TCB Femur Traumatic inflammatory 
periosteal reaction 
Healed 
European Shorthair, 10, F FNA Nasal cavity Lymphoma Lost 
Boxer, 2, M FNA - Fibrosarcoma Euthanasia 
Mix, 2, F FNA Retrobulbar Abscess - osteomyelitis Healed post-surgery 
Boxer, 3, M FNA Retrobulbar Fibrosarcoma Euthanasia 
European Shorthair, 7, F FNA Tympanic bulla Squamous cell Carcinoma Lost 
Mix, 8, M FNA Spine Non-diagnostic Lost 
F=female; FNA = fine-needle aspiration; M=male; TCB = tissue-core biopsy. 
* Histopathology revealed the presence of fibro-connective tissue on the fracture surface of the bone fragment. 
The fibro-connective tissue did not seem to be the sequel to acute or chronic diseases, nor to any pathological 
healing process. The cancellous bone of the fragment was normal as was the bulk of the articular cartilage 
examined. These findings suggest a possible "incomplete fusion" of the centres of ossification rather than a true 
fracture of the radial carpal bone or alternatively a "fatigue fracture". 
 
 In 6 animals, FNA (3 orbital masses, 1 spinal and 1 nasal lesion and 1 mass involving 
the tympanic bulla) were taken and underwent cytologic examination. In 17 animals, TCB 
were taken (7 long bone, 3 nasal, 3 spinal and 2 facial bone lesions as well as 1 articular and 1 
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pelvic lesion) with subsequent histopathologic examination. The nasal biopsies were taken 
through the maxillary bone for tissue-core biopsies and in one case, through a palate cleft for 
FNA. All seventeen TCB samples were diagnostic (accuracy 100%). Five out of six FNA 
were diagnostic with an accuracy of 83.3%. Four out of 5 of the cytologic examinations were 
confirmed by histopathology after euthanasia. In one dog, the abscess was confirmed by 
aspiration of purulent material and the clinical condition improved after antibiotic therapy. In 
one dog, cytologic quality of the sample was insufficient containing only blood. The overall 
mean accuracy was 95.7%.  
 Mild to moderate transient nasal bleeding was observed after biopsies of the nose. 
Two dogs had mild, transient worsening of the lameness during 3 days after biopsy. Major 
complications were not noticed. Results are summarized in Table 1. Neoplastic disease was 
diagnosed in 12 dogs and in both cats. Two dogs had osteomyelitis in the spine and orbit, 
respectively. In 6 dogs, benign diseases were assessed. In one dog, Staphylococcus was 
isolated from the spine, while no bacteria were isolated from a distal metaphysis of the radius 
in another dog. 
 
DISCUSSION 
 
 Our results suggest percutaneous freehand CT-guided FNA or TCB is accurate for 
diagnosis of primary or secondary bony lesions in small animals. The accuracy of TCB and 
FNA was 100 % and 83.3 %, respectively. Of the 6 FNA, only a vertebral aspirate was non-
diagnostic. Unfortunately, this dog was lost to follow-up. The overall mean accuracy was 95.7 
%. However, for better assessment of the accuracy of the FNA, more patients are needed.  
 Choice of the biopsy needle as well as animal positioning depends on the site and 
dimensions of the lesion and its distance from the skin. In the present study, a 12 ga bone 
needle was chosen for biopsy, where the use of biopsy needles from 8 ga (Rimondi et al., 
2001) to 12 ga (Yao et al., 1999) has been recommended. For aspiration, a 22 ga spinal needle 
was used. The use of a fine needle such as 22 ga rather than a larger one has been 
recommended to avoid suction of blood (Finn-Bodner and Hathcock, 1993). In the present 
study, the size of the bone needle may explain its high accuracy.  
 No major complications such as hemorrhage or fracture occurred in the present study. 
Only mild bleeding after the biopsy of the nose was observed. Such complications have to be 
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considered in relation to risks of alternative methods and the risk of an incorrect diagnosis. 
We considered assessment of biopsy-associated pain difficult, because dogs were already 
lame before the procedure. However, we noted worsening of the lameness during the first 3 
days after biopsy in 2 dogs. In one patient, complete bone destruction resulted in mild needle 
displacement because of lack of bony support. However, this did not influence success of the 
biopsy. Some difficulties were encountered in selecting the correct angle for biopsy of the 
spine, and to keep the animals in the same position during the biopsy procedure. In one 
patient, the examination had to be restarted. However, a diagnostic sample was finally 
obtained. 
 The intravenous injection of iodinated non-ionic contrast medium added useful 
information. In fact, the contrast enhancement allowed biopsy of viable tissue and avoidance 
of large vessels.  
 Compared to fluoroscopy or US, CT allowed better evaluation of the exact location 
and extent of a lesion and good visualization of the needle. CT is superior to fluoroscopy 
because of higher contrast resolution and, representing a sectional imaging technique, CT is 
free of superimposition. Further, there is no X-ray exposure of veterinarians or technicians. 
There are no problems with overlapping air or bone, as with US. Moreover, US-guided biopsy 
is reported to be less accurate than CT-guided biopsy. In a recent study, 5 out of 23 US-
guided aspirates of bone lesions were not diagnostic (Samii et al., 1999). Magnetic resonance 
imaging has a higher contrast resolution than CT, but requires needles made of special non-
ferromagnetic stainless steel.  
 The time required for the procedure depends on the site of the lesion, the skill of the 
radiologist and the available equipment. In the present study, time needed for the procedure 
varied from 20 minutes for biopsy of the nose and long bones to 60 minutes for biopsy of the 
spine. Although CT-guided biopsy is reported to be less dependent on operator skills than US 
(Tidwell and Johnson, 1991), we believe that skill is important to short time and safety of the 
procedure.  
 In conclusion, CT-guided biopsy of bone-associated lesions in small animals appears 
to be a safe and accurate technique. Use of intravenous contrast medium increases accuracy 
and decreases complication rates. 
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* Ago spinale, Artsana. Cuneo, Italy 
§ Ago biopsia, Gallini S.R.L.. Mirandola (MO), Italy. 
 CT/e, GE. Bologna, Italy. 
Somatom AR.T, Siemens. AG 91301 Forchheim, Germany. 
 CT MAX, GE. Milwaukee Winsconsin. 
 Diprivan, Astra Zeneca S.p.A. Basiglio (MI), Italy. 
 Forane , Abbott. Campoverde di Aprilia (LT), Italy. 
 ** Visipaque, Nycomed Imaging AS. Milano, Italy. 
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SUMMARY 
 
 Diagnosis of pulmonary lesions on the basis of history and physical examination 
is often challenging. Diagnostic imaging is therefore of paramount importance in this 
field. Radiology has traditionally been considered the elective diagnostic procedure for 
these diseases. Nonetheless it is often not possible to differentiate 
inflammatory/infectious lesions from neoplastic disease. A correct cyto-histopathologic 
diagnosis is therefore needed for an accurate diagnosis and subsequent prognostic and 
therapeutic plan. In human medicine computed tomography and computed 
tomography-guided biopsy are indicated in the presence of lesions, which are not 
adequately diagnosed with other procedures.  
 In the present study 38 dogs and 11 cats of different sex, breed and size 
underwent either computed tomography-guided lung fine-needle aspiration, or tissue-
core biopsy or both. Clinical examination, haematology and chest radiography were 
performed on all animals. In this study 46 samples out of 56 were diagnostic (82.14%). 
Ten cases, either because of uncertainty or because only blood was aspirated, were 
considered non-diagnostic. Sixteen out of 49 cases showed complications (32.6%). 
Temporary pneumothorax was seen in 13 cases, mild hemorrhage in three cases. No 
major complications were encountered. 
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INTRODUCTION 
 
 A correct cyto-histopathologic diagnosis is essential for an accurate diagnosis and 
subsequent prognostic and therapeutic plan of pulmonary lesions (Withrow and Lowes, 1981; 
Withrow, 1991; Finn-Bodner and Hathcock, 1993; Vignoli et al., 2003; Vignoli et al., 2004). 
Imaging modalities such as fluoroscopy, ultrasonography (US), computer tomography (CT) 
and magnetic resonance imaging (MRI) have to be considered to take guided biopsy samples 
(Murphy, 1983; Finn-Bodner and Hathcock, 1993; Vignoli et al., 2004a). Ultrasound-guided 
fine-needle aspiration (FNA) or tissue-core biopsy (TCB) of intrathoracic masses adjacent to 
the thoracic wall, have been described in human medicine (Sheth et al., 1999; Yang, 2000) as 
well as in veterinary medicine (Finn-Bodner and Hathcock, 1993). Furthermore, the use of the 
Doppler examination allows the evaluation of the lesion visualisation (Finn-Bodner and 
Hathcock, 1993). In human medicine CT and CT-guided biopsies are indicated in the 
presence of lesions, which are not adequately diagnosed with other procedures (Murphy, 
1983; Lucidarne et al., 1998; Kang et al., 1999; Yao et al., 1999; Dash and Tripathy, 2001; 
Duda et al., 2001; Hänninen et al., 2001; Rimondi et al., 2001). 
 In veterinary medicine some studies have been published on the CT-guided biopsy of 
the brain with stereotactic devices (Koblik et al., 1999; Giroux et al., 2002; Moissonnier et al., 
2002), while the description of the freehand technique CT-guided biopsy in animals is still 
limited (Tidwell and Johnson, 1991; Finn-Bodner and Hathcock, 1993; Tidwell and Johnson, 
1994a; Tidwell and Johnson 1994b; Tidwell and Johnson, 1998; Vignoli et al., 2002; Di 
Giancamillo; 2003; Henninger, 2003; Vignoli et al., 2003; Vignoli et al., 2004a; Vignoli et al., 
2004b) and few details and results are available about the sensitivity of the technique. In one 
study, the accuracy of the CT-guided biopsy in bone and soft tissue associated diseases was 
described; TCB had an accuracy of 100% both for inflammatory/infectious and neoplastic 
diseases, while with FNA the accuracy was 75%, with an overall mean accuracy of 94% 
(Vignoli et al., 2002). In another study, the overall mean accuracy was 95.7 % (100% TCB 
and 83.3 % FNA) (Vignoli et al., 2004a). In 2 recent reports on the CT-guided biopsy of the 
intra-thoracic lesions, accuracy of 65% for FNA and 83% for TCB (Zekas and Crawford, 
2004) and 82 % for FNA was shown (Vignoli et al., 2004b). The latter was a preliminary 
study on CT-guided FNA and did not take into account TCB.  
 The purpose of this study is to assess the percentage of diagnostic samples and 
complications of CT-guided FNA and TCB in the lung lesions of the dog and cat. 
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MATERIALS AND METHODS 
 
 A retrospective study on 49 animals, 38 dogs and 11 cats of different breed, sex and 
size, underwent freehand technique CT-guided biopsy of the lung. Forty-four FNA and 12 
TCB were performed. Only a single specimen was taken in each lesion, in order to limit the 
possible complications. Seven dogs underwent both FNA and TCB. All the cats underwent 
FNA. The use of a different technique (FNA or TCB) was chosen mainly on the base of the 
size of the lesion. Before the procedure all the animals were checked with blood and urine 
examinations. Thoracic radiograph was always performed before CT examination. All the 
animals were studied under general anesthesia and monitored during the procedure (sedation 
30‘ before the study with: Butorphanol 0.1-0.2 mg/kg i.m. and Acepromazine 0.025 mg/kg 
i.m. depending on the clinical condition of the dog or cat followed by.induction with Propofol 
2-8 mg/kg i.v. and maintenance with a mixture of Oxygen and Isofluoran). 
 The CT examinations were performed to assess the extent of the lesion, to diagnose 
eventual metastases, and to take an aimed biopsy. For the studies were used a spiral CT in 
Sasso Marconi (BO)* and Milan°, and third generation CT in Pisa§. The gantry was never 
tilted and the slice thickness was 3-5 mm depending of the size of the lesion. The CT was 
repeated after intravenous contrast medium** administration at the dose of 400-800 mg/kg, 
depending the size of the animal. The CT study was reviewed with lung (WW 1500, WL 550) 
and soft tissue (WW 300-350, WL 35-40) windows, and then with the same soft tissue 
window the biopsy was performed. In some cases to decrease the streak artefacts a bone 
window (WW 2000-4000, WL 450) was obtained. For FNA a 90 mm long, 21 ga spinal 
needle
#
 was used.  For the TCB a 14 ga guide with stylet and stopper and a 16 ga spring 
loaded automated needle, with 23 mm of excursion
oo
 was used. Both the guide and the 
automated needle were calibrated at one cm. The technique has been modified from 
previously described techniques (Tidwell and Johnson, 1991; Vignoli et al., 2004b). All the 
animals were positioned in a manner to have easier access to the lesion based on the location 
of the lesion seen on thoracic radiographs.  
 A surgical preparation was done before the CT study. After the CT study was 
completed, the assessment of the location and extent of the lesion and the selection of the 
target plane was done. The target plane was chosen in an area with significant changes to 
obtain viable tissue samples. Areas suspected to be necrotic (with no contrast enhancement) 
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and large vessels were avoided. Then, the CT table was moved to the target plane, which was 
indicated by the laser light in the gantry. In this plane, the site for insertion of the needle was 
subjectively chosen and marked with a sterile radiopaque metal marker. Subsequently, a few 
additional slices in the area of the marker were acquired to measure the distance from the skin 
to the proximal and distal borders of the lesion and to the area to biopsy. Those measurements 
facilitated the choice of correct depth and the angle of insertion of the needle. 
 The CT table was moved out of the gantry so that the spinal needle (for FNA) or the 
metallic guide (for TCB) could be placed and advanced in the preset distance and angle after a 
skin incision. The position of the spinal needle/guide tip was evaluated with additional images 
and correction of needle placement was performed when indicated before the lesion was 
sampled. For FNA once the needle was in a correct position, the stylet was retracted and 
suction with a syringe was applied. For TCB when the metallic guide was considered to be in 
a correct position, the stylet was retracted and the automated needle inserted within the guide 
to the lesion and a tissue-core biopsy was obtained (Fig. 1).  
 
Figure 1: Doberman, male, 7-year-old, in right lateral recumbency. CT of the thorax after contrast medium 
administration with a soft tissue window (WW 300, WL 35). A slice is selected where to biopsy (A). Then 
measurements from the skin to the lesion at different depth are taken (B). Based on this information, the guide is 
inserted within the lesion and the position is checked with some more slices from the same area. Streak artifacts 
due to the metal are visible (C). Final diagnosis was adenocarcinoma. 
 
Some more images in the area of the lesion were taken in order to check for complications. 
All the animals were clinically monitored after the procedure for 2 to 24 hours depending on 
eventual presence and the severity of the complication. 
 
RESULTS 
 
 The tip of the needle was visualized within the lesion in all the patients. The diagnosis 
was reached in 46 out of 56 samples (Tables 1 & 2).  
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  Table 1: CT-procedure and results of 38 dogs and 11 cats with thoracic lesions. 
Cases  
number 
Signalement: breed, age in years (y), 
sex (M: male; F: female) 
Location of the  
lesion in the lung  
lobe 
Biopsy  
technique* 
Histological/Cytological  
diagnosis 1 Miniature Poodle, 10 y, F Right middle  FNA Carcinoma 
2 Miniature Poodle, 11 y, F Right caudal  FNA Non-diagnostic 
3 Vlaamse Koehond, 7 y, F Left caudal  FNA Carcinoma 
4 Boxer, 11 y, M Left caudal  TCB Carcinoma 
5 Epagneul Breton, 9 y, F Right cranial  FNA Carcinoma  
6 Griffon Kort., 10 y, M Right caudal  FNA Carcinoma 
7 Mix, 10 y, F Left caudal FNA Carcinoma 
8 Mix, 10 y, M Right middle FNA Non-diagnostic 
9 Mix, 11 y, F Right caudal FNA Carcinoma 
10 Mix, 14 y, F Left caudal TCB Carcinoma 
11 Bernese Mountain, 8 y, M Right middle FNA Malignant 
histiocytosis 12 German Shepherd, 10 y, F Left caudal FNA Carcinoma 
13 German Shepherd, 11 y, M Left caudal FNA Carcinoma 
14 Pekingese, 11y, F Left caudal FNA Carcinoma 
15 Pointer, 13 y, F Left caudal FNA Non-diagnostica 
16 Rottweiler, 9 y, M Right caudal FNA Abscess 
17 Siberian Husky, 12 y, F Right cranial FNA Granuloma 
18 Schnauzer, 9 y, F Right middle FNA Non-diagnostic 
19 English Setter, 8 y, F Right caudal FNA Abscess 
20 German Shepherd, 7 y, M Right cranial FNA Carcinoma 
21 Mix, 9 y, M Right cranial FNA Non-diagnostic 
22 Mix, 12 y, M Right caudal TCB Carcinoma 
23 Mix, 7 y, F Left cranial FNA Carcinoma 
24 Mix, 10 y, M Right middle FNA Carcinoma 
25 German Shepherd dog, 11 y, M Right middle FNA Carcinoma 
26 Mix, 9 y, F Left cranial FNA Carcinoma 
27 Mix, 14 y, M Left caudal FNA + TCB Carcinoma 
28 Labrador Retriever, 17 y, M Right caudal FNA Abscess 
29 Mix, 4 y, F Right accessory FNA + TCB Carcinoma 
30 Boxer 9 y, M Right middle FNA + TCB Abscess 
31 Boxer, 8 y, M Left caudal FNA Non-diagnostic 
32 Weimaraner, M 18 m Left caudal FNA Abscess 
33 Mix, 12 y, F Left caudal FNA + TCB Carcinoma 
34 Bernese Mountain, 7 y, M Left caudal FNA + TCB FNA: Carcinoma 
TCB: Non-diagnostic 35 Dobermann, 12 y, M Right caudal FNA + TCB Carcinoma 
36 Airdale terrier, 12 y, M Right caudal TCB Carcinoma 
37 Labrador Retriever, 9 y, F Left caudal FNA +TCB Carcinoma 
38 Bernese Mountain, 8 y, M 
 
Right middle TCB Carcinoma 
      FNA = fine-needle aspiration; TCB = tissue-core biopsy 
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Table 2: CT-procedure and results of 11 cats with thoracic lesions. 
Cases  
number 
Signalement: breed, age in years (y), 
sex (M: male; F: female) 
Location of the  
lesion in the lung  
lobe 
Biopsy  
technique* 
Histological/Cytological  
diagnosis 1 European Shorthair cat, 13 y, F Left caudal FNA Carcinoma 
2 European Shorthair cat, 8 y, M Left cranial FNA Cyst 
3 European Shorthair cat, 9 y, M Left cranial FNA Non-diagnostic 
4 Persian cat, 13 y, M Right caudal FNA Carcinoma  
5 Persian cat, 9 y, F Right caudal FNA Non-diagnostic 
6 Siamese cat, 15 y, M Left caudal FNA Carcinoma 
7 Persian cat, 13 y Right caudal FNA Carcinoma 
8 European Shorthair cat, 14 y, F Left cranial FNA Carcinoma 
9 European Shorthair cat, 13 y, M Right caudal FNA Abscess 
10 European Shorthair cat, 18 y, M Right caudal FNA Non-diagnostic 
11 European Shorthair cat, 15 y, M Left caudal FNA Carcinoma 
      FNA = fine-needle aspiration; TCB = tissue-core biopsy 
 
Thirty-five of 44 FNA (79.5%) and 11 of 12 TCB (91.7%) were diagnostic. Nine of 44 FNA 
were considered not diagnostic because only blood was aspirated. One TCB was not 
diagnostic because of the presence of fibrous tissue only. In the same dog the FNA was 
diagnostic for carcinoma. The overall mean accuracy was 82.1%. Sixteen out of 49 cases 
showed complications (32.6%). Mild to moderate pneumothorax was present in 12 cases, and 
a severe pneumothorax is one case after a TCB. However, this did not require any surgical 
intervention. A pneumothorax was present after 5 FNA (11.4 %) and 8 TCB (66.7%) 
procedures (Fig. 2).  
 
Figure 2: Same dog as Fig. 1. Positioned in lateral recumbency. Lung window: a mild to moderate 
pneumothorax was present on this post-biopsy image. 
 
The deeper the lesion, the more severe the pneumothorax, with a range of 2 to 7 cm. 
However, in some deep lesion no pneumothorax was visible. In three cases a mild 
haemorrhage was present in deep lesions, with collapse of the dependent lung when animals 
were positioned in lateral recumbency.  
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 Neoplastic lesions were detected in 31 cases (25 dogs and 6 cats). Thirty were 
carcinomas and one malignant histiocytosis (Fig. 3).  
 
            
Figure 3: Crossbreed, female, 12-year-old. Computed tomography of the thorax in sternal recumbency and with 
a soft tissue window (WW 300, WL 40). After contrast medium administration a large mass is visible in the left 
caudal lung lobe is shown with inhomogenous enhancement (A). Biopsy phase: the guide is inserted within the 
lesion. Streak artifacts are visible (B). Final diagnosis was adenocarcinoma. 
 
Benign lesions like abscesses, cysts or granulomas were diagnosed in 8 cases (6 dogs 
and 2 cats) (Fig. 4). 
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Figure 4: Domestic shorthair cat, female, 15-year-old. CT of the thorax in sternal recumbency and with a lung 
window (WW 1500, WL 550). (A) A small nodule, about 1 cm in diameter is visible in the right caudal lung 
lobe. Measurements (B) and phase of the biopsy (C) are visible. Final diagnosis was a granuloma. 
 
DISCUSSION  
 
 Computed tomography of the thorax is a very sensitive but not very specific method, 
even with the use of contrast medium (Vignoli et al., 2004). A study on 5 cats showed that the 
density of the lesion measured with Hounsfield Units is not specific for a neoplastic disease 
versus an inflammatory disease and that contrast medium does not give different enhancement 
(Henninger, 2003). Therefore a biopsy is needed to establish a final diagnosis. In this study 
the percutaneous CT-guided biopsy was used to obtain a diagnostic sample in 46 out of 56 
biopsy samples, with an overall mean accuracy of 82.1%. Tidwell and Johnson (1994), 
reported 4 lung and 1 cranial mediastinal biopsies. All the samples, 3 evaluated for cytology 
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and 3 for histopathology, were diagnostic (Tidwell and Johnson, 1994). One study has 
reported an accuracy of 65% for FNA and 83% for TCB (Zekas and Crawford, 2004). In 
human medicine, the diagnostic accuracy of core biopsy under CT guidance is reported to be 
rather high, between 88% (Lucidarne et al. 1998) and 95% (Hänninen et al., 2001), and is of 
85% for FNA. It has been reported in the literature that carcinomas exfoliate better than 
sarcomas (Withrow,1991; Finn-Bodner and Hathcock, 1993), and since most of the 
malignancies in the lung are carcinomas, this may explain why there is quite a high accuracy 
with CT-guided FNA of lung pathology.  
 The localization of the needle tip in the percutaneous CT-guided biopsy has been 
considered the key point for the success of the procedure. It is of paramount importance to 
differentiate between the true tip of the needle from the impression of the false tip, which is 
visible when the CT scan comprises only the angled needle (Vignoli et al., 2003). It has been 
reported that the ―low density‖ artifact visible immediately adjacent to the distal part of the tip 
of the needle may create a false positive impression; therefore the correct position of the 
needle must be determined by evaluating the shape and the distinctness of the tip rather than 
the ―low density‖ artifact (Tidwell and Johnson, 1994).  
 The choice of biopsy needle and the position of the animal depend on the localisation, 
dimension and distance from the skin surface to the lesion (Finn-Bodner and Hathcock, 
1993). In the present study, 21 ga spinal needle for FNA was considered. A fine needle has 
been recommended in order to avoid aspiration of blood (Finn-Bodner and Hathcock, 1993). 
For TCB, a 14 ga calibrated guide with stylet was employed, which functioned as a support 
for the 16 ga calibrated automated needle. Indeed, the length of the needle and the weight of 
the handle of the needle did not allow to biopsy directly with the automated needle. The use 
of different techniques (FNA or TCB) was chosen mainly based on the size of the lesion, 
considering the 23 mm of excursion of the automatic needle. Because of that excursion, we 
considered it not possible to take a TCB in lesions smaller than 4 cm. 
We observed some complications like 3 mild haemorrhages and 12 cases of mild to 
moderate pneumothorax. Only one severe pneumothorax was seen after a TCB, but none of 
them required surgical intervention. Most of the complication were seen after TCB, probably 
due to the larger size of the guide compared to that of the needle used for FNA and biopsy of 
deep lesions; however, with some deeply located lesions neither haemorrhage nor 
pneumothorax was observed. Those complications were not correlated to the size of the 
lesion. In one study it was reported that the deeper the lesion, the more severe the 
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pneumothorax was likely to be, but no clinical manifestations were noted in that study 
(Henninger, 2003). Since passing trough more lung tissue is needed to get into a deeper 
lesion, we can speculate that this could be the reason of the higher number of pneumothorax 
complications seen in deeply located lesion. In one dog, the severe pneumothorax created was 
probably the cause of not being able to obtain a diagnostic sample. In the same case the FNA 
was diagnostic for carcinoma. In human medicine, pneumothorax is the most common 
complication of percutaneous CT-guided lung biopsy and ranges from eight to 61% (Saji et 
al., 2002, Shantaveerappa et al., 2002). In one study on 289 patients, it was reported that 
application of a thoracic drainage was necessary in 14% of the cases. In the same study it was 
reported that deeper lesions, which require a wider trajectory angle, were risk factors for 
pneumothorax (Saji et al., 2002). In another study is was reported that the transthoracic needle 
biopsy can be performed with high-diagnostic yield in patient with iatrogenic stable 
pneumothorax caused by other procedures, like CT-guided biopsy, US-guided biopsy or 
transbronchial lung biopsy (Chang et al., 2003). The respiratory movements did not cause 
problems during the procedure. However, it is important not to move the animal during the 
procedure to avoid loosing the target so that one has to restart the examination. 
 In this study the animals were positioned in different recumbencies with the goal to 
reach the lesion easier on basis of the localization of the lesion obtained by radiography. 
However, it is our opinion that lateral recumbency should be avoided, if possible, because 
metastases may be missed because of the partial collapse of the dependent lung. Another 
option is to position the animal in ventrodorsal or dorsoventral recumbency in order to 
examine for metastases, and then reposition the animal in lateral recumbency to obtain the 
biopsy. The latter method, which includes a retake of the scout views and a new scanning of 
the mass implies a longer examination time and a new injection of contrast medium, however.  
 The intravenous administration of non-ionic iodinated contrast medium, can give 
useful information. Indeed, the enhancement of the lesion allows to biopsy viable tissue and 
to avoid large vessels (Withrow, 1991, Tidwell and Johnson, 1994; Vignoli et al., 2004).  
 CT allows better evaluation of the extent of the lesion than US and fluoroscopy 
(Withrow, 1991; Vignoli et al., 2004), also in lesions surrounded by gas as opposed to in US 
(Finn-Bodner and Hathcock, 1993; Vignoli et al., 2004). The CT is a more sensitive technique 
to examine for metastases compared to fluoroscopy and conventional radiology (Withrow, 
1991).   
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 Some disadvantages of CT compared to other techniques are reported, however (Finn-
Bodner and Hathcock, 1993; Vignoli et al., 2004). The time for the whole procedure is 
different depending on the size, location of the lesion, experience of the radiologist and CT 
machine available. With a spiral CT the whole procedure (scanning and biopsy) takes from 5 
to 30 minutes. 
 In conclusion, CT-guided biopsy is a safe and accurate technique. CT is useful for 
examination of areas that are difficult to reach with other techniques, especially lesions 
surrounded by gas. Moreover, within the same examination it is possible to assess the possible 
presence of metastases. The only limitation that we observed in this study was related to the 
size of the mass to be punctured as lesions smaller than 4 cm could not be punctured. 
 
 
 
*  GE Pro-Speed Power Spiral CT, Bologna, Italy. 
°  Philips PQ2000S Spiral CT, Milano, Italy. 
§  GE CT MAX third generation CT, Milano, Italy. 
** Omnipaque, Amersham Health, Milano, Italy. 
# Ago spinale, Artsana. Cuneo, Italy. 
°°Angelo Franceschini, S.Lazzaro (BO), Italy. 
Chapter 3.2: CT-guided FNA and TCB of lung lesions 
93 
REFERENCES 
 
Chang YC, Wang HC, Yang PC. (2003). Usefulness of computed tomography-guided 
transthoracic small-bore coaxial core biopsy in the presence of pneumothorax. J Thorac 
Imaging 18:21-26. 
 
Dash BK, Tripathy SK. (2001). Comparison of accuracy and safety of computed tomography 
guided and unguided transthoracic fine needle aspiration biopsy in diagnosis of lung lesions. J 
Assoc Phys India 49:626-629 (Abstr). 
 
Di Giancamillo M, Secchino B, Stefanello D, Caniatti M. (2003). Impiego della biopsia con 
ago sottile TC-guidata nella pratica clinica veterinaria: proposta di un protocollo di 
esecuzione. Atti X° Congresso SICV, Bologna, 19-21 Giugno, 416-423. 
 
Duda SH, Johst U, Krahmer K, Pereira P, Konig C, Schafer J, Huppert P, Schott U, Bohm P, 
Claussen CD. (2001). Technique and results of CT-guided percutaneous bone biopsy. 
Orthopade 30:545-550. 
 
Finn-Bodner ST and Hathcock JT. (1993). Image-Guided Percutaneous Needle Biopsy: 
Ultrasound, Computed Tomography, and Magnetic Resonance Imaging. Semin Vet Med Surg 
(Small Animals) 8:258-278. 
 
Giroux A, Jones JC, Bohn JH, Duncan RB, Waldron DR, Inzana KC. (2002). A new device 
for stereotactic CT-guided biopsy of the canine brain: design, construction, and needle 
placement accuracy. Vet Radiol Ultrasound 43:229-236. 
 
Hänninen EL, Vogl TJ, Felix R. (2001). CT-guided biopsies of Pulmonary Lesions. Acta 
Radiol 42:151-158. 
 
Chapter 3.2: CT-guided FNA and TCB of lung lesions 
94 
Henninger W. (2003). Use of computed tomography in the diseased feline thorax. J Small 
Anim Pract 44:56-64. 
 
Kang M, Gupta S, Khandelwal N, Shankar S, Gulati M, Suri S. (1999). CT-guided fine-
needle aspiration biopsy of spinal lesions. Acta Radiol 40:474-478. 
 
Koblik PD, LeCoteur RA, Higgins RJ, Fick J, Kortz GD, Sturges BK, Pascoe PJ. (1999). CT-
guided biopsy using a modified Pelorus Mark III stereotactic system: experience with 50 
dogs. Vet Radiol Ultrasound 40:434-440. 
 
Lucidarne O, Howarth N, Finet JF, Grenier PA. (1998). Intrapulmonary lesions: Percutaneous 
Automated Biopsy with a Detachable, 18-gauge, Coaxial Cutting Needle. Radiology 207:759-
765. 
 
Moissonnier P, Blot S, Devauchelle P, Delisle F, Beuvon F, Boulha L, Colle MA, Lefrancois 
T. (2002). Stereotactic CT-guided brain biopsy in the dog. J Small Anim Pract 43:115-123. 
 
Murphy WA. (1983). Radiologically guided percutaneous musculoskeletal biopsy. Orthop 
Clin North Am 14:223-241. 
 
Rimondi E, Busacca M, Moio A, Molinari M, Trentani F, Trentani P, Tigani D. (2001). 
Computerized tomography guided biopsy in the diagnosis of neoplastic and inflammatory 
lesions of the pelvis. Radiol Med (Torino) 101:60-65. 
 
Saji H, Nakamura H, Tsuchida T, Tsuboi M, Kawate N, Konaka C, Kato H. (2002). The 
incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-
guided lung biopsy: the angle and the needle trajectory is a novel predictor. Chest 121:1521-
1526.  
 
Chapter 3.2: CT-guided FNA and TCB of lung lesions 
95 
Shantaveerappa HN, Mathai MG, Byrd RP jr, Karnad AB, Mehta JB, Roy TM. (2002). 
Intervention in patients with pneumothorax immediately following CT-guided fine-needle 
aspiration of pulmonary nodules. Med Sci Monit 8:401-404. 
 
Sheth S, Hamper UM, Stanley DB, Wheeler JH, Smith PA. (1999). US guidance for thoracic 
biopsy: a valuable alternative to CT. Radiology 210:721-726. 
 
Tidwell AS, Johnson KL. (1991). Indication and Technique for CT-Guided Biopsy. In 
Proceedings, 19
th
 Annual Meet Am College of Vet Surgeons, pp. 78. 
 
Tidwell AS, Johnson KL. (1994a). Computed Tomography- Guided Percutaneous Biopsy: 
Criteria for Accurate Needle Tip Identification. Vet Radiol Ultrasound 35:440-444. 
 
Tidwell AS, Johnson KL. (1994b). Computed Tomography-Guided Percutaneous Biopsy in 
the Dog and Cat: Descritpion of the Technique and Preliminary Evaluation in 14 Patients. Vet 
Radiol Ultrasound 35:445-456. 
 
Tidwell AS, Johnson KL. Application of CT guided biopsy in small animals. Vet Radiol 
Ultrasound 1998; 39:238 (abstr). 
 
Vignoli M, Rossi F, Pozzi L, Ohlerth S, Corlazzoli D, Terragni R, Sarli G. (2002). CT-guided 
biopsy in the axial and appendicular skeleton. EAVDI/ECVDI Annual Meeting, Murcia 
(Spain), pp. 76.  
 
Vignoli M, Citi S, Rossi F, Terragni R, Corlazzoli D, Marchetti V. (2003). Studio preliminare 
sulla biopsia TC-guidata del polmone nel cane. Atti X° Congresso SICV, Bologna, pp. 393-
397. 
 
Chapter 3.2: CT-guided FNA and TCB of lung lesions 
96 
Vignoli M, Ohlerth S, Rossi F, Pozzi L, Terragni R, Corlazzoli D, Kaser-Hotz B. (2004a). 
Computed tomography-guided fine-needle aspiration and tissue-core biopsy of bone lesions in 
small animals. Vet Radiol Ultrasound 45:125-30. 
 
Vignoli M, Di Giancamillo M, Citi S, Rossi F, Terragni R, Corlazzoli D, Laganga P, Gnudi 
G. (2004b). Study on CT-guided fine-needle aspiration of the lung in the dog and cat. 
Veterinaria 18:1-6. 
 
Withrow SJ, Lowes N. (1998). Biopsy Techniques for Use in Small Animal Oncology. J Am 
Anim Hosp Assoc 17:889-902. 
 
Withrow SJ. (1991). The Three Rules of Good Oncology: Biopsy, Biopsy, Biopsy! J Am 
Anim Hosp Assoc 27:311-314. 
 
Yang PC. (2000). Ultrasound-guided transthoracic biopsy of the chest. Radiol Clin North Am 
38:323-343. 
 
Yao L, Nelson SD, Seeger LL, Eckardt JJ, Eliber FR. (1999). Primary Musculoskeletal 
Neoplasm: Effectiveness of Core-Needle Biopsy. Radiology 212:682-686. 
 
Zekas LJ, Crawford JT. (2004). Computer Tomography-guided sampling of intrathoracic 
lesions in thirty dogs and cats. Vet Radiol Ultrasound 45:184. 
 
Chapter 3.3: Evaluation of a manual biopsy device “Spirotome” 
97 
 
CHAPTER 3.3 
_______________________________________ 
 
EVALUATION OF A MANUAL BIOPSY DEVICE 
(“SPIROTOME”) ON FRESH CANINE ORGANS 
(LIVER, SPLEEN, KIDNEYS) AND FIRST 
CLINICAL EXPERIENCES IN ANIMALS 
 
 
 
Massimo Vignoli, Virginie Barberet, Koen Chiers, Luc Duchateau, Barbara Bacci,  
Rossella Terragni, Federica Rossi, Jimmy H. Saunders 
 
 
 
 
 Clinica Veterinaria dell‘Orologio, Sasso Marconi, Italy. 
 Faculty of Veterinary Medicine, Ghent University, Belgium.  
 
 
Adapted from: Eur J Cancer Prev 2010 Accepted
Chapter 3.3: Evaluation of a manual biopsy device “Spirotome” 
98 
 
SUMMARY 
 
 Several methods for obtaining specimens from abdominal organs have been 
described. Imaging-guided biopsy, particularly ultrasound-guided biopsy, is the most 
frequently used in clinical trials. The aim of this study was to evaluate the diagnostic 
quality of histological samples obtained with a manual biopsy device (Spirotome) on 
biopsies of the liver, spleen and kidney, in fresh canine organs and in live animals in a 
clinical trial.  
 The study was divided into two different parts: one on normal fresh canine 
organs with a total of 60 biopsies, 20 in liver, spleen and kidney respectively; and one on 
clinical patients, having biopsied 35 lesions in 28 animals (25 dogs and 3 cats) for a total 
of 105 biopsies. All the biopsy samples were considered satisfactory on canine cadavers, 
and all specimens were diagnostic in clinical cases. The technique was accurate and safe 
and no major complications were noted.  
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INTRODUCTION 
 
 Several methods for obtaining tissue samples from abdominal organs have been 
described in both human and veterinary medicine including blind percutaneous biopsy, 
imaging-guided biopsy, biopsy during laparotomy or laparoscopy, and endoscopic biopsy (De 
Rycke et al., 1999; Winter et al., 2008). Of these methods, imaging (mainly ultrasound)-
guided biopsy is the most frequently used in the daily clinic as well as in clinical trials 
(Iwamoto, 1999; Perry, 2001; Bear et al., 2003). The success of a biopsy procedure depends 
on multiple factors some of which being controllable, others incontrollable. The needle type is 
a main factor for successful biopsy. There is a large variety of needles for tissue-core biopsy. 
The most commonly used are the spring-loaded needle and the biopsy gun (Hoppe et al., 
1986; Parker et al., 1989; Bernardino, 1990; Nyland et al, 2002). In recent needles, an 
excursion of the tip of 15 mm (for small masses or organ biopsies) or 23 mm (for large 
masses) can be selected (Nyland et al., 2002). A manual or automated needle type can be 
chosen. If the biopsy is performed with a manual needle, an assistant might be necessary to 
help the operator during the procedure. Instead, if an automated needle is used, the operator 
can manipulate the transducer and take the biopsy on its own.  
 Ultrasound-guided biopsies of the liver, spleen and kidneys are commonly performed. 
However, the results are sometimes unsatisfactory (De Rycke et al., 1999; Cole et al., 2002). 
Recently, a new biopsy device called ―Spirotome‖ has been developed and successfully used 
for biopsy of the breast, lymph node, peritoneum, bone and liver in humans (Janssens et al., 
2002; Rotenberg et al., 2004; Nasr et al., 2006; Cusumano et al., 2008).  
To our knowledge this technique has not yet been studied for spleen and kidney biopsy 
in both human and animals. The aim of this study was to evaluate a manual biopsy device 
(Spirotome*) for biopsy of the liver, spleen and kidney, in fresh canine organs and in live 
animals in a clinical trial.  
 
MATERIAL AND METHODS 
Spirotome device 
The Spirotome needle is a non-magnetic inox needle that can be resterilized up to 5-10 
times (Fig. 1 and 2). 
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Figure 1: The 4 elements that compose a Spirotome needle: 1=the cutting needle, 2=the trocar, 3=the receiving 
needle (helix), 4=the releasing device. 
   
                             
Figure 2: (A) Close-up image of the helix. (B) Ultrasonographic appearance of the helix during a biopsy 
procedure. 
 
Cadaver and clinical studies 
The study was divided into 2 different parts: one on fresh canine organs (further cadaver 
study) and one on clinical patients (further clinical study). 
 
Cadaver study 
 In the first part of the study a 10 ga ―Spirotome‖ with a cutting length of 18 mm was 
used to perform 2 biopsies on the liver, spleen and kidney on 10 fresh canine cadavers for a 
total of 60 biopsies. Nine dogs were large breed dogs (3 German Shepherd, 2 Labrador 
Retriever and 4 crossbreed). One dog was a Jack Russell. The mean age of the dogs was 5-
year-old (range 2 to 7-year-old). All the 10 dogs died for unrelated diseases (eg. spinal or 
head trauma) to the organs to be biopsed. This study used the technique previously reported 
by Rotenberg et al. (2004). The biopsies were taken just after death. 
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 Each tissue sample was immediately placed in a 10% formalin solution and labelled. 
The specimens were then processed for histological examination, embedded in paraffin and 
cut into 5-micron thick sections. The slides were stained with hematoxylin and eosin using 
standard histological techniques. The histological quality of the samples was evaluated with 
light microscopy using general criteria (common for the three organs) and specific criteria for 
each organ. General criteria were the edge of the samples, fragmentation of the samples and 
sample size (length, width and area). For the hepatic samples, specific criteria were the 
presence of bile canaliculi and hepatocytes, number of centrolobular veins and portal spaces 
per section. For the splenic samples, the presence of haemorrhage, capsule, white and red pulp 
was used. Specific criteria for the renal samples were the presence of cortex and medulla and 
the number of glomeruli per section.  
 
Clinical study 
 The second part of this study was a clinical trial. Twenty-eight animals (25 dogs and 3 
cats), with 35 different lesions diagnosed by ultrasound and/or haematology/biochemistry, 
underwent US-guided biopsy with a Spirotome biopsy needle similar to the one used in the 
cadaver study. The cases were selected by the fact that clinical sings, US examination and/or 
haematology/biochemistry suggested an indication for a biopsy. 
 The dogs were of different breeds, 13 females and 12 males, with an average age of 8 
years (range 1-17 years). Three domestic short hair cats, all female, were also included in the 
study. Before the biopsy, all animals were submitted for radiographs of the thorax and 
haematology-biochemistry. A coagulation profile like activated partial thromboplastin time 
(aPTT), one-stage prothrombine time (OSPT), bleeding time and urinalysis were performed. 
If the coagulation profile was abnormal and the biopsy considered essential for the 
management of the case, desmopressin (4µg/kg, s.c.) was given one hour prior to the 
procedure. The animals were anesthetized with diazepam 0.2 mg/kg, fentanyl 2 mcg/kg and 
propofol 4-7 mg/kg given intravenously. For each lesion, 3 biopsies were taken with the 
Spirotome for a total of 105 biopsies. The specimen were fixed with 10% buffered formalin 
and examined for their diagnostic quality using the same histological criteria as for the 
cadaver study. Cases were also evaluated on the basis of the histological diagnosis to assess 
possible differences in the quality of sample with different types of lesions. For the 
measurements, a Leica QWin Plus 3.2 software was used. Statistical analysis was performed 
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with t Student test to assess correlation between sample criteria and type of lesion. Results 
were considered statistically significant with p<0,05. 
 All the animals were re-evaluated with US just after the biopsies and two hours later, 
in order to assess possible complications, like haemorrhage. In case of abdominal free fluid, a 
haematocrit was repeated to see if there were substantial variations from the pre-operative 
sample. All the animals with benignancy were followed clinically and with abdominal US in 
the next months to follow up the disease. 
 The quality of the samples obtained on cadavers and in patients was compared for 
diagnostic quality for the liver, spleen and kidneys. The biopsy needles were cleaned and 
sterilized allowing them to be re-used. 
 All the biopsies, cadavers and clinical cases, were taken by one interventional 
radiologist. 
 
RESULTS 
Cadaver study 
 For the liver, 50% of the samples showed fragmentation of the histological section. 
The mean length of the hepatic specimens was 9.39 mm ± 3.34, the mean width was 2.34 mm 
± 0.73 and the mean area was 21.18 mm
2 
± 7.67, mean number per section of portal spaces 
was 4.9 ± 1.83 and of centrolobular veins 1.9 ± 1.41. Hepatocytes and bile canaliculi were 
detected in all cases.  
 For the spleen, 50% of the samples showed fragmentation of the histological section. 
The mean length of the splenic samples was 8.67 mm ± 2.62, the mean width 2.60 mm ± 0.54 
and the mean area 22.35 mm
2
 ± 7.33. White pulp and red pulp were present in 95% and 100% 
of cases respectively. Capsule was present in 20% of cases and haemorrhage was observed in 
50% of cases.  
 
 For the kidneys, 95% of the samples showed fragmentation of the histological section. 
The mean length of the kidney samples was 17.07 mm ± 2.08, the mean width 1.77 mm ± 
0.18 and the mean area 27.91 mm
2 
± 5.46. Cortex was present in the 100% of the cases and 
medulla in the 20%. Mean number of glomeruli per section was 31.85 ± 8.07.  
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 In all the biopsies of different organs there was sharpness of cut edges. 
 
Clinical study 
 All biopsy procedures were performed within 10 minutes. All the samples were 
considered satisfactory. In the liver, 6 lesions were neoplastic (n) and 15 non-neoplastic (nn). 
For the liver, 63 biopsies were evaluated; 61.9% of the samples showed fragmentation of the 
histological section. The mean length of the hepatic specimens was 9.9 mm (11.88 mm ± 4.62 
for n and 9.26 mm ± 4.81 for nn), the mean width 2.79 mm (3.52 mm ± 0.82 for n and 2.57 
mm ± 0.99 for nn) and the mean area 23.96 mm
2
 (32.22 mm
2
 ± 17.03 for n and 20.66 mm
2
 ± 
14.84 for nn). The mean number of portal spaces per section was 1.57 (0.5 ± 0.54 for n and 
2.00 ± 1.41 for nn) and of centrolobular veins 1.76 (0.3 ± 0.5 for n and 2.33 ± 1.71 for nn). 
Hepatocytes and bile canaliculi were detected in 95.2% of cases (83% in n and 100% in nn).  
 
 For the spleen, 2 lesions were neoplastic and 4 non-neoplastic. Eighteen splenic 
samples were evaluated; 66.6% of the samples showed fragmentation of the histological 
section. The mean length of the splenic samples was 9.7 mm (8.67 mm ± 0.79 for n and 9.38 
mm ± 2.66 for nn), the mean width 2.93 mm (2.6 mm ± 0.67 for n and 3.31 mm ± 0.86 for nn) 
and the mean area 22.58 mm
2
 (19.71 mm
2 
± 2.27 for n and 25.11 mm
2
 ± 9.7 for nn). White 
pulp and red pulp were present in 67% (50% for n and 75% for nn) and 83% (50% for n and 
100% for nn) of cases respectively. Capsule was observed in 50% (0% for n and 75% for nn) 
and hemorrhage was observed in 50% of cases (50% for n and 50% for nn).  
 
 For the kidney, 4 lesions were neoplastic and 4 non-neoplastic; 13% of cases showed 
fragmentation of the sample. The mean length of the renal samples was 16.93 mm (19.47 mm 
± 5.87 for n and 16.54 mm ± 1.99 for nn), the mean width 3.29 mm (2.98 mm ± 1.06 for n and 
3.29 mm ± 0.91 for nn) and the mean area 47.24 mm
2 
(55.73 mm
2 
± 27.11 for n and 47.25 
mm
2 
± 10.00 for nn). Renal cortex and medulla were present in 87.5% of cases (33.33% for n 
and 100% for nn). The average number of glomeruli was 4.75 (3.00 ± 2.64 for n and 7.25 ± 
1.7 for nn).  
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 A comparison between neoplastic and non-neoplastic cases was performed. 
Statistically significant higher values were observed in the liver for the following criteria: 
width of samples, number of portal spaces and number of centrolobular veins. In the kidney 
statistically signifcant higher number of glomeruli was observed in non-neoplastic cases. In 8 
dogs and 2 cats, there was mild abdominal bleeding, seen on ultrasound, after the procedure 
from which the animals recovered well without additional intervention. The haematocrit of 
these animals differed less than 10% compared to the one before the procedure. Bleeding on 
the biopsy site seen in 5 dogs, was easily controlled after the procedures with compression on 
the site of puncture for 2 min and no haematoma was seen. One cat (case 27) never recovered 
completely from the anesthaesia and started a disseminated intravascular coagulation 2 hours 
after the procedure with haemorrhage at the biopsy site and within the subcutis of the 
abdomen, and cutaneous petechiae, whilst there was only a minimal amount of free fluid 
within the abdomen. The patient died 4 hours after the procedure. 
Table 1: Summary of the clinical cases. 
Breed Gender 
Age 
(years) Organs biopsed Histopathological diagnosis Complications 
Boxer female 7 kidney + liver 
kidney: glomerulonephritis; liver: 
neuroendocrine carcinoma none 
West Higland 
White Terrier female 12 
two different 
liver lesions  
hydropic degeneration with mild, chronic 
portal lymphohistiocytic hepatitis and 
intrahepatic cholestasis none 
Crossbreed female 13 
two different 
liver lesions  
left lobe: nodular hyperplasia; right side: 
hydropic degeneration, intrahepatic cholestasis mild haemorrhage 
Crossbreed female 17 spleen haemangioma  none 
German Sheperd male 4 kidney carcinoma none 
Springer Spaniel male 4 kidney B cell lymphoma none 
Crossbreed female 10 liver hepatocellular adenoma none 
Crossbreed female 13 liver nodular hyperplasia mild haemorrhage 
Crossbreed female 17 spleen + liver 
spleen:  hyperthrophy muscular trabeculae and 
extramedullary haematopoiesis; liver: 
lymphocytic hepatitis and extramedullary 
haematopoiesis mild haemorrhage 
Labrador male 8 liver haematoma none 
Labrador female 11 liver hepatocellular adenoma  none 
York Shire  male 5 kidney glomerulonephritis mild haemorrhage 
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Labrador 
Retriever female 10 kidney metastatic thyroid carcinoma none 
Rottweiler male 2 liver normal liver (severe gastroduodenitis) none 
DSH cat female 15 
 left + right 
kidneys 
left kidney: end-stage kidney; right kidney: 
glomerulonephritis and tubulonephrosis  none 
Crossbreed male 12 spleen follicuar hyperplasia none 
Crossbreed female 13 liver cirrhosis mild haemorrhage 
Giant Schnauzer  male 5 liver chronic hepatitis 
none (desmopressin 
used) 
DSH cat female 2 liver + spleen 
liver: centrolobular necrosis; spleen: 
granulomatous splenitis and vasculitis mild haemorrhage 
Crossbreed male 15 liver + spleen liver + spleen: leiomyosarcoma none 
Cavalier KCS male 3 liver hydropic-vacuolar degeneration none 
Rottweiler female 5 liver chronic hepatitis none 
Chow Chow  female 10 liver eosinophilic hepatitis mild haemorrhage 
Bull Mastif male 1 liver atrophy, portal vein hypoplasia (shunt) none 
Crossbreed male 13 liver haemangioma  mild haemorrhage 
Czech wolf dog  male 5 spleen thrombosis and infarction mild haemorrhage 
Dachshund male 10 liver hepatocellular carcinoma none 
DSH cat female 13 Kidney carcinoma 
mild haemorrhage 
within the abdomen. 
Died due to DIC 
 
No biopsy samples were lost during the retraction of the needle. Each needle could be used 
for 10 cases, before needing to be changed because of lack of cutting. During the first 
biopsies, a helper was needed to handle either the ultrasound transducer or the biopsy needle. 
With increased experience, it was possible to handle both the transducer and the needle and 
thus to perform the biopsy without a helper. 
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DISCUSSION 
 
 It has been reported that a biopsy system has to produce large core tissue specimens, 
large enough to be suitable for micro-array research, so that multiple slices (up to 1000) can 
be made from one single core. The specimen has to be of high quality with the tissue 
remaining completely undamaged during the harvest. The system must be relatively 
inexpensive and easy to manipulate for use in multicentric clinical trials in different countries. 
The tissue dimensions should comply with immunohistochemistry and molecular biology, as 
these are the new research methods to consider. The method should be patient friendly 
because the patient is the first partner in clinical trials. Given the problems in taking biopsies 
from normal tissues, the new system should not encounter more difficulties in normal 
compared with malignant tissues or in situ and mixed lesions. Finally, for the purpose of 
reliability, it would be best if the different steps of biopsy could be filmed so that the tissue 
specimen entering the device is unmistakably into the lesion seen on medical imaging. Indeed, 
reliable biopsies are not the least important thing in oncological research (Rotenberg et al., 
2004). Clinical data of a new manual biopsy system ―Spirotome‖ have been recently reported 
in human being for breast (Rotenberg et al., 2004; Janssens et al., 2006; Cusumano et al., 
2008) and liver (Nars et al., 2006) biopsies.  
 On fresh canine cadaver, the ―Spirotome‖ device provided samples of diagnostic 
quality for liver, spleen and kidney. Moreover, in a previous study, the quality of the samples 
was considered superior to the ones taken with a spring-loaded needle of the same size 
(Barberet et al., 2007). In all the clinical cases, and in all the biopsies from the same animal 
the samples were adequate to allow a complete histological examination and a definitive 
diagnosis for the presence of both lesion and targeted tissue. A higher degree of fragmentation 
was observed in samples obtained from liver and spleen compared with kidney. This can be 
explained because of the friability of these organs compared with kidney. Best biopsy quality 
was obtained for renal samples. 
 Interestingly, the histological quality of the liver samples was always better in the 
neoplastic lesions compared with the non neoplastic ones (mean length 11.88 mm for n and 
9.26 mm for nn; mean width 3.52 mm for n and 2.57 mm for nn; mean area 32.22 mm
2
 for n 
and 12.12 mm
2
 for nn), while for spleen and kidney the results were similar. These results 
however were statistically significant only for the width of liver samples. To explain that, a 
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possible reason is that the normal liver has a scant stromal tissue, whilst in some tumors of 
our serie, particularly in the mesenchimals, but also in the carcinomas, a large amount of 
supportive fibrovascular stroma, was present, giving to the tissue more firmness. In the 
kidney, the adequacy of samples for the diagnosis requires the presence of at least five 
glomeruli per section (Mostbeck et al., 1989). In the present study the mean value was 4.75 
(range of 0-9) in clinical patients, with 2 cases showing only neoplastic tissue in the entire 
biopsy. In the cadaver specimens, the number of glomeruli was more than satisfactory with a 
mean of 31.85. The number of glomeruli in samples of diseased patient depends on the 
disease process and its stage of evolution. Some of the values obtained in the analysis of 
biopsied tissues (bile canaliculi, hepatocytes, centrilobular veins and portal tracts for liver; 
white and red pulp from spleen; cortex medulla and glomeruli for kidney) were 
underestimated due to the presence of space-occupying lesions such as neoplasia. Hence, the 
evaluation of benign parenchymal diseases alone would show higher values for the above 
criteria. Twenty percent of the biopsies of fresh cadavers showed renal cortex and medulla, 
while 100% of the clinical trial non neoplastic renal biopsies had cortex and medulla. The 
difference can be due to the atrophy of the cortex correlated with the lesions. 
 The use of a 10 ga large core biopsy needle also explains the positive results obtained 
in the present study. However, despite the use of a large core biopsy system, no major 
complication was noted. A few cases showed mild haemorrhage after the procedure. Only one 
cat died due to disseminated intravascular coagulation but this is very unlikely to be due to the 
biopsy procedure because systemic haemorrhage was noted and there was only a mild amount 
of free fluid within the abdomen. 
 The possibility to sterilize the biopsy needle reduces the cost of the procedure. We 
could biopsy up to 10 clinical cases for a total of about 30 biopsies with one needle, therefore 
the final cost for a single biopsy is similar to the cost using a spring-loaded needle. 
 In conclusion, in the present study we have found the Spirotome system an easy and 
safe technique for abdominal ultrasound-guided biopsies, especially for neoplastic lesions of 
the liver. 
 
 
 
*Spirotome: Medinvents, Hasselt, Belgium. 
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SUMMARY 
 
 This paper reports 3 clinical cases of needle tract implantation of neoplastic cells 
on the abdominal and thoracic wall after ultrasound fine-needle aspiration biopsy. 
Primary tumors were two transitional cell carcinomas of the urinary bladder (2 dogs) 
and one pulmonary adenocarcinoma (1 cat). All 3 masses grew up along the needle tract. 
To our knowledge, the seeding of pulmonary adenocarcinoma cells after FNAB on the 
thoracic wall has never been reported in veterinary medicine. 
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INTRODUCTION 
 
 The hypothesis of possible spreading of neoplastic lesions during surgical procedures 
was first suggested by human surgeons (Gerster, 1885). Abdominal wall metastasis after 
resection of a gastric carcinoma was reported by Mayo in 1913. In the following years, many 
authors stated that biopsy procedures of neoplastic lesions could be a cause of local 
recurrence because of malignant cell dissemination by the needle into the surrounding tissue 
(Ochsner et al., 1947; Crile, 1956).  
 In human medicine, dissemination of neoplastic cells after ultrasound (US)-guided 
fine needle aspiration (FNA) has been referred following percutaneous aspiration of different 
lesions of the head, neck, thorax and abdomen. Carcinomas of the lung, liver, pancreas and 
prostate are over represented. The incidence of this complication seems to be low. For hepatic 
carcinomas, needle tract implantation has been reported to occur in 1.6% (Kosugi et al., 
2004). In a study including 4365 FNA of lung lesions, dissemination of neoplastic cells was 
considered an extremely rare event (Kim et al., 2003).  
 In veterinary medicine, post-surgical recurrence at the abdominal wall of a transitional 
cell carcinoma of the urinary bladder was described by Anderson et al. (1989). In small 
animals, only 3 cases of needle tract implantation after FNA have been published (Nyland et 
al., 2002). All 3 cases were carcinomas of the urinary bladder, urethra and prostate, 
respectively .  
 This paper reports 3 cases (2 dogs and one cat) of neoplastic cells spreading to the 
abdominal and thoracic wall after US-guided FNA of 2 transitional cell carcinomas of the 
urinary bladder and one adenocarcinoma of the lung.  
 
CASE 1 
 
 A 10-year-old male, crossbreed dog was presented because of macrohematuria. Blood 
work and standard radiographs of the chest were normal. Ultrasound examination of the 
abdomen showed an irregular, inhomogeneous thickening of the urinary bladder wall in the 
area of the trigone with loss of normal wall layering. A freehand FNA was performed using a 
22 ga hypodermic needle connected to a 5 mL syringe. Cytological analysis revealed a 
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transitional cell carcinoma of the bladder. The owner of the dog decided for a palliative 
chemotherapy protocol with meloxicam (Metacam, Boeringher Ingelheim) 0.1 mg/kg/s.i.d.  
 After 10 months, the dog was represented because of a large ulcerated para-penile 
mass. This lesion was about 6 cm in diameter and involved the subcutaneous tissue of the 
abdominal wall in the same area where the FNA was performed (Fig. 1).  
 
 
Figure 1: Large ulcerated mass in the parapenile area 10 months after fine needle aspiration biopsy of the 
urinary bladder transitional cell carcinoma. 
 
 The US examination showed a diffuse, hyperechoic thickening of the urinary bladder 
wall up to 1 cm of thickness. There was complete loss of normal wall layering and irregular 
mucosal surface. In the bladder lumen some hyperechoic structures were visible and 
interpreted as blood clots (Fig. 2). 
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Figure 2: Ultrasonographic examination of the urinary bladder. There is diffuse, hyperechoic thickening of the 
urinary bladder wall. In the bladder lumen, some hyperechoic structures were visible and referred to blood clots. 
 
 In the area of the subcutaneous mass, the abdominal wall appeared thickened up to 3 
cm with a complex mass appearance. A Tru-cut biopsy sample from the abdominal wall 
lesion was taken for histopathology and examined with Hematoxylin-Eosin as well as by 
immunohistochemistry using Ck pool (Dako) as primary antibody. Tissue sections were 
immersed in 0.01 M buffered citrate (pH 6.0) and microwaved at 600 W for 20 minutes to 
retrieve antigens. All slides were rinsed with 0.05 M tris Buffered Saline (TBS pH 7.6) and 
0.01 % Tween 20 treated with 1% hydrogen peroxide and again rinsed with TBS and Tween 
20. Slides were incubated with the primary antibody overnight at 4°C and again rinsed with 
TBS and Tween 20. After treatment for 30 minutes at room temperature with ENVISION they 
were incubated with diamino-benzidine solution containing 0.015 hydrogen peroxide for the 
peroxidase coloring reaction and counterstained whit Mayer‘s hematoxylin.  
 In the peritoneal serosa, proliferation of anomalous transitional epithelial cells of the 
urinary bladder was visible, organized in a tubular and papilla-tubular well-differentiated 
pattern (Fig. 3). 
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Figure 3: Microscopic sections of the subcutaneous mass, hematoxylin. In the peritoneal serosa, proliferations of 
anomalous transitional epithelial cells of the urinary bladder are visible. The cells show irregular margins, large 
nuclei, with evident nucleoli, and eosinophilic cytoplasma.  
 
 The cells had irregular margins, large nuclei with evident nucleoli and eosinophilic 
cytoplasma. Moderate fibroplasia of the serosa was also present confirming spreading of 
carcinomatous cells to the abdominal wall. Due to a poor prognosis, the owner requested 
euthanasia.  
 
CASE 2 
 
 A 12-year-old castrated male, crossbreed dog underwent cystotomy to remove bladder 
stones. Forty days after surgery, the dog was presented because of pollakiuria, hematuria. The 
ultrasound examination showed multiple hyperechoic areas in the wall of the urinary bladder 
and a hyperechoic irregular, broad-based mass protruding into the lumen from the ventral wall 
of the bladder neck. An US-guided FNA of the urinary bladder mass was performed using a 
22 ga needle connected to a 5 mL syringe. Cytology confirmed the diagnosis of a transitional 
cell carcinoma of the bladder. The dog was treated with 1 mg/kg/s.i.d. piroxicam (Feldene, 
Pfizer) and 5 mg/kg b.i.d. cimetidine (Zytac, Intervet) per os. 
 After 3 months, an irregular, ulcerated, 5 cm large mass was present in the abdominal 
wall along the tract where the FNA has been taken. Because of worsening of the clinical 
condition of the dog, the owner requested euthanasia. A post-mortem FNA of the ulcerated 
mass was taken and the spreading of tumoral cells was confirmed.  
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CASE 3 
 
 A 12-year-old Persian female cat, was presented because of lameness of the right 
forelimb. The cat was in good body condition. Both forelimbs were radiographically normal 
but lung abnormalities were detected, and therefore a complete radiographic examination of 
the thorax was performed. Two rounded, well-defined lung nodules, about 2 cm in diameter, 
were visible in the right middle and left caudal lung lobes (Fig. 4).  
 
 
Figure 4: Right lateral radiographic view of the thorax.of a Persian female cat. There are two lung nodules in the 
right middle and left caudal lung lobes. Mutlifocal ventral vertebral spondylosis is visible. 
 
 It was possible to visualize one of the lung nodules with US and an US-guided FNA 
was performed with a 22 ga needle connected to a 5 mL syringe. A lung adenocarcinoma was 
diagnosed on cytology. Two weeks later, a 1 cm large mass was present on the thoracic wall, 
in the same area of the US-guided aspiration. Cytology of the mass confirmed needle tract 
implantation of the lung adenocarcinoma to the thoracic wall (Fig. 5).  
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Figure 5: Fine needle aspirate from one of the pulmonary nodules: a large, three-dimensional cluster is 
surrounded by pinkish necrotic debris. Note the strongly cohesive arrangement of pleomorphic epithelial cells 
having high nuclear-to-cytoplasmic ratios. (MGG-40x).  
 
 After 10 days, the clinical condition of the cat worsened because of hemesis and 
anorexia. The owner elected euthanasia and did not allow necropsy. 
 
DISCUSSION 
 
 Fine-needle aspiration is a commonly used procedure both in human and veterinary 
medicine to obtain samples for cytological or bacteriological examination. This technique is 
easy to perform, quick, minimally invasive and inexpensive. Because of small size of the 
needle, complications related to organ damage or post-procedure hemorrhage are rare 
(Leveille et al., 1993). However, needle tract implantation of neoplastic cells has been 
reported in humans and in dogs (Nyland et al., 2002). Dissemination of neoplastic cells in the 
surrounding tissue by US-guided aspiration can occur during retraction of the needle. 
Nevertheless, tumor autotransplantation studies indicate that at least one million cells are 
necessary for successful implantation (Southam and Brunschwig, 1961). It is known that only 
few cells can survive because of local protective mechanisms and the host immune response, 
which are able to destroy abnormal cells (Smith, 1981). Moreover, Weiss et al. (1988) 
estimated that only one of 100.000-1.000.000 neoplastic cells entering the circulation may 
eventually produce metastasis. It has been stated that during FNA the number of disseminated 
tumor cells are normally less than that required for successful implantation (Glasgow et al., 
1988) explaining why needle tract implantation is rarely observed (Kosugi et al., 2004). 
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 Factors which can influence implantation of neoplastic cells include specific features 
of the tumor and technical aspects of the procedure. Cell implantation is related to tumor 
aggressiveness (Sacchini et al., 1989). In veterinary medicine, seeding of transitional cell 
carcinoma of the urinary tract (bladder or urethra) has also been reported by Nyland et al. 
(2002) indicating that this tumor type is more prone to spread compared to others. One of the 
2 dogs with transitional cell carcinoma of the urinary bladder (case 2) underwent cystotomy 
40 days before FNA: It is not completely excluded that tumor spread occurred during surgery. 
However, the abdominal mass was located on the opposite side of the surgical scar and this 
suggests that the FNA was the cause of the seeding. 
 To our knowledge, the Persisan cat of this report (case 3) is the first published case of 
needle tract seeding of a lung adenocarcinoma following FNA in veterinary medicine. 
Unfortunately, there is no data available about biological behavior of lung adenocarcinomas 
in small animals. Lung biopsies are not routinely performed in clinical practice because 
pulmonary lesions are often difficult to reach. If the lesion has contact with the thoracic wall, 
US-guided FNA or tissue-core biopsy can be performed. Otherwise only fluoroscopy or CT-
guided procedures are possible. It could be hypothesized that lung adenocarcinomas in cats 
may have high propensity to spread to the thoracic wall after FNA. However, in a recent study 
including 39 cases of CT-guided FNA of the lung (30 dogs and 9 cats) this complication has 
not been reported (Vignoli et al., 2004). In this cat, the time between the aspiration procedure 
and the development of the chest wall mass was only 2 weeks. Recent published data in 
humans (Kim et al., 2003) has shown a recurrence time between 2 and 16 months. This could 
confirm a possible high aggressiveness of the lung adenocarcinoma in this cat.    
 In humans, it has been assessed that the risk of tumor seeding increases with the size 
of the needle and the number of passes. To reduce this complication, small diameter needles 
(22 ga or smaller) have been suggested (De May, 2000). Injection of foreign material into the 
lesion, e.g. ethanol, saline solution, contrast medium or local anaesthetics, may promote 
dissemination of cells increasing the pressure inside the mass (De May, 2000). The best way 
to avoid the risk of needle tract implantation is to change the technique of sampling, if 
possible. If a malignant neoplasia of the urinary tract and prostate is suspected, cytological 
samples can be obtained by urethral catheterisation. This procedure consists of an external 
manipulation of the bladder and urethra during suction by an urethral catheter. A similar US-
guided procedure (Lamb et al., 1996) offers the advantages to guide the tip of the catheter into 
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the lesion. With this technique, the probability to obtain a diagnostic result is higher and the 
captured sample can be large enough to permit histological examination.  
 In conclusion, even if needle tract implantation after FNA is a rare event in small 
animals, it should be considered, especially if a FNA of carcinomas of the urinary tract is 
performed. On the basis of only one case it cannot be stated that lung adenocarcinomas in cats 
have a higher risk of neoplastic dissemination. 
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SUMMARY 
 
 Vascular perfusion was assessed in 10 dogs without prostatic abnormalities and 
26 dogs with prostatic disease using contrast-enhanced ultrasound. The time to reach 
peak contrast intensity (TTP) and peak perfusion intensity (PPI) were measured and 
histological biopsies were collected from each dog. Biopsies confirmed normal prostate 
(n=10), benign prostatic hyperplasia (n=11), mixed benign pathology (n=9), prostatitis 
(n=1), prostatic malignancy (adenocarcinoma [n=4]; leiomyosarcoma [n=1]).  
 In normal dogs, mean PPI was 16.8 % + 5.8 SD and mean TTP was 33.6 + 6.4 sec. 
Benign conditions overall were not statistically different from normal dogs (p>0.05); for 
benign prostatic hyperplasia mean PPI was 16.9 + 3.8 % and mean TTP was 26.2 + 5.8 
sec; for mixed benign pathology mean PPI was 14.8 + 7.8% and mean TTP was 31.9 + 
9.7 sec; for prostatitis PPI was 14.2% and TTP was 25.9 sec. 
 The malignant conditions overall had perfusion values that differed from the 
normal dogs (p<0.05), although evaluation of the data for individual malignancies did 
not demonstrate a consistent trend; for adenocarcinomas the PPI was numerically 
higher with a mean of 23.7 + 1.9% and the mean TTP was 26.9 + 4.8 sec, whilst for the 
dog with leiomyosarcoma values were numerically lower with a PPI of 14.1% and TTP 
of 41.3 sec.  
 Contrast enhanced ultrasound appears to offer some ability to document 
differences in perfusion that may differentiate between malignant and benign lesions, 
although studies with larger numbers of animals are required to confirm this 
contention. 
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INTRODUCTION 
 
 Prostatic disease is frequently seen in small animal practice. The most common 
conditions affecting the canine prostate include benign prostatic hyperplasia, prostatitis, 
prostatic cysts, and prostatic neoplasia (Smith, 2008). Unfortunately the diagnosis of 
malignant prostate disease is challenging since benign and malignant lesions may, at least 
initially, have a similar clinical and imaging appearance (Jemal et al., 2007).  
 In humans, prostate cancer is the most frequent type of cancer and shows a similar 
spectrum of prostatic diseases (Culty and Richard, 2006). The diagnosis of prostate cancer in 
men is made on histological biopsy results. The decision whether or not to take biopsies is 
dependant on prostate specific antigen (PSA) levels, digital rectal examination and transrectal 
ultrasound findings. However, the value of each of these investigations is limited 
(Mitterberger et al., 2007). The optimal PSA cut-off level is not yet determined neither is the 
optimal number of biopsies required to obtain a diagnosis (Norberg et al., 1997; Djavan et al., 
2000; Shah et al., 2005; Eichler et al., 2006). The search for improved diagnostic techniques 
continues and a variety of other imaging modalities have been reported in human medicine, 
including computed tomography, magnetic resonance imaging, positron emission tomography 
and single photon emission computed tomography (Fuchsjäger et al., 2008; Delgado Bolton et 
al., 2009; Deutscher et al., 2009; McMahon et al., 2009; Weinreb et al., 2009).  
 Contrast enhanced ultrasound (CEUS) has been reported to be useful for the 
differentiation of human prostate cancer from other non-malignant conditions (Mitterberger et 
al., 2007; Wink et al., 2008). Using CEUS, a bolus of contrast agent is injected intravenously 
and then the gland monitored to measure accumulation of the contrast. The analysis of US 
contrast agent bolus kinetics yields various time-intensity curve parameters that qualitatively 
describe regional perfusion. Peak perfusion intensity (PPI) is expressed as a percentage of 
background intensity, and the time to reach peak intensity (TTP) is expressed in seconds from 
the time of injection. These values are representative of different aspects of vascularisation of 
the region of interest. 
 In the dog, prostatic carcinoma is a highly malignant neoplasm with a prevalence of 
0.2–0.6% (Weaver, 1981). Prostatic neoplasia must be distinguished from non-malignant 
prostatic disease so that appropriate treatment can be initiated. One recent study reported that 
the presence of mineralization in the prostate identified with either abdominal radiographs or 
ultrasound is considered highly suspicious for prostatic neoplasia (Bradbury et al., 2009). 
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Prostatic mineralization is considered even more suspicious for neoplasia if the dog is 
neutered (Bradbury et al., 2009). However, other studies have reported that mineralization 
also occurs in chronic bacterial prostatitis, benign prostatic concretions (calculi), and prostatic 
abscess (Feeney et al., 1987; Burk and Ackerman, 1996). In the dog there have been few 
investigations of the plethora of imaging modalities used in humans, and US is considered to 
be the imaging modality of choice for evaluation of the prostate gland. Unfortunately, despite 
providing excellent images, it may be difficult to differentiate between benign and malignant 
canine prostatic diseases with US because of their similar appearance when using this 
technique (Mahaffey et al., 1995), and specific colour-flow Doppler patterns have not been 
described for the different prostatic conditions. A recent study reported the normal prostatic 
and urethral perfusion values in dogs (Russo et al., 2009). Normal values for PPI ranged 
between 15.5 and 17.6%, depending on the view (longitudinal or transverse) and on the side 
(right or left), whilst for TTP ranged between 29.9 and 37.5 sec. 
 The aim of the present study, which we believe is the first in veterinary medicine to 
describe the use of CEUS in dogs with prostatic disease, was to evaluate the perfusion 
kinetics in dogs without prostatic abnormalities and those with prostatic disease confirmed 
histologically as being benign or malignant. 
 
MATERIALS AND METHODS 
 
 Ten dogs without prostatic abnormalities (mean age of 2.2 + 0.9 SD years), and 
weighing between 6 and 37 kg and 26 dogs with prostatic disease (mean age of 9.3 + 2.3 SD 
years), and weighing between 7.5 and 43.0 kg were included in this study. Ethical approval 
for the study was gained through the normal procedure of the University of Naples. Dogs 
were examined at the Veterinary Clinic dell‘Orologio; 20 dogs were referred with clinical 
signs unrelated to prostatic disease, whilst 6 were referred for tenesmus, haematuria, stiff gait 
and/or anorexia. After physical examination, all dogs were evaluated with abdominal 
radiographs, serum chemistry profile, complete blood cell count and urinalysis (data not 
shown), before ultrasonography was performed.  
 This study used the technique previously reported by Russo et al. (2009). A 20 ga 
intravenous cannula was placed in the cephalic vein. All patients then underwent general 
anaesthesia with diazepam 0.2 mg⁄kg IV and propofol 4 mg⁄kg IV, which were given until 
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tracheal intubation was possible. Anaesthesia was maintained with isoflurane (1–3% in 
oxygen) and intravenous saline was administered throughout the procedure. All dogs were 
maintained in right lateral recumbency and haemoglobin oxygen saturation, heart rate, blood 
pressure and CO2(carbon dioxide)-saturation were monitored continuously throughout 
anaesthesia. 
 Ultrasound examination of the caudal abdomen was performed with a 5-7.5 MHz 
linear transducer with coded harmonic capability (Mylab 30, Esaote-CnTI System, Esaote, 
Genova, Italy). Maximum prostatic width was measured in the transverse plane and a colour 
Doppler examination was performed at a rate of 0.7-1.4 frames per sec. Once a focal or 
diffuse prostatic lesion was identified in the dogs with prostatic disease the contrast study was 
undertaken.  
 A second-generation contrast agent SonoVue (Sulphur hexafluoride microbubbles; 
Bracco Imaging S.p.A., Milan, Italy) and dedicated CEUS analytical software (Contrast 
Tuned Imaging - CnTI
TM
 - Contrast Tuned Imaging Technology, Esaote, Genova, Italy) were 
used. The mechanical index was always lower than 0.1 (range 0.05–0.1) to reduce the 
acoustic impact of the US waves on the micro bubble contrast agent, and to increase the 
persistence of the contrast medium in the blood. A single focal zone was placed in the deepest 
part of the prostate. The overall gain and time-gain compensation were set so that no signal 
from the prostatic parenchyma was present and only a very low background signal from the 
prostatic capsule was maintained to ensure an anatomic reference in the image. The contrast 
medium was injected into the cephalic vein at a dose of 0.03 mL⁄kg of prepared solution (5 
mg⁄ mL) followed by a rapid bolus of 5 mL of saline solution. The timer was activated at the 
moment of starting the injection (T0) and the flow of contrast medium into the prostate gland 
was observed in real-time. Care was taken to keep the US transducer in exactly the same 
position for at least 1.5 minutes. The entire examination was digitally recorded. Thereafter, a 
single trans-abdominal US-guided Tru-Cut biopsy of a random portion of the gland (dogs 
without prostatic abnormalities) or a targeted biopsy (dogs with prostatic disease) was taken 
using a 16 ga spring loaded biopsy needle (Russo et al., 2009). 
 All the recorded videos were reviewed and the enhancement pattern was subjectively 
described. A commercial software application (QONTRAST, Milan, Italy) was then used to 
construct time-intensity curves. A frame was selected every 10 sec for the first 1.5 minute of 
the videos. For focal prostatic lesions a region of interest (ROI) was manually drawn in each 
area considered to be abnormal. In cases of diffuse prostatic lesions, two ROIs were drawn. 
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For all of these, the best image possible was choosen, either in a longitudinal or transverse 
plane. Random ROIs were selected for the normal dogs. The PPI (expressed as a percentage) 
and the TTP (expressed in sec) were calculated from T0.  
 All values were calculated as mean and median (±SD) and reported descriptively for 
each of the histological classification groups. For prostatic width, comparisons were made 
between values for normal dogs (n=10) with dogs with prostatic disease (n=26); whilst for 
perfusion parameters, comparisons were made between normal dogs (n=10), dogs with benign 
lesions (n=21) and dogs with malignant lesions (n=5). Data were not normally distributed and 
therefore non-parametric analysis was performed using the Welch‘s t test (GraphPad 
Software, Inc.); values were considered to be significant when p<0.05. 
 
RESULTS 
 
 Prostatic biopsy was successfully performed in each case without adverse effects. 
Histopathological examination of the biopsies demonstrated normal prostate (n=10), benign 
prostatic hyperplasia (n=11), prostatitis (n=1), prostatic malignancy (adenocarcinoma [n=4]; 
leiomyosarcoma [n=1]), and mixed benign pathology (n=9). The latter cases included benign 
prostatic hyperplasia together with either prostatitis or metaplasia. 
 For the 10 normal dogs, B-mode ultrasound demonstrated a homogenous moderately 
hyperechoic parenchyma and a prostatic width between 2.0 and 3.5 cm. In each of the 26 
abnormal dogs, prostate width was larger than published values for body size (Atalan et al., 
2008) and actual prostatic width was between 3.5 and 8.5 cm; prostatic width differed 
significantly for dogs without prostatic abnormalities compared with those with prostatic 
disease. The most common findings in cases of benign prostatic disease (hyperplasia, 
prostatitis, mixed pathology) were a heterogenous parenchyma (16 cases) (of these 11 cases 
also had cystic lesions). In the remaining 5 cases there was only prostatomegaly with a 
homogenous parenchyma. In one case of prostatitis, peri-prostatic free fluid was visible 
ventrocranially. When the prostate was very large, there was a progressive decreasing 
echogenicity of the organ in the far field sometimes making imaging very difficult.  
In the 4 cases of prostatic adenocarcinoma mild to marked mineralization of the prostatic 
gland was observed. In the one case with prostatic leiomyosarcoma, a well-defined 
hypoechoic area was documented. The latter was always hypoechoic compared with the 
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surrounding parenchyma also during the contrast study, during the wash in, at the peak, and 
the wash out phases (Fig. 1). 
 
   
Figure 1: Contrast-enhanced ultrasound of a 6-year-old, Jack Russell Terrier dog with a final diagnosis of 
leiomyosarcoma. Early wash in phase (A), late wash in phase (B), and early wash out phase (C), respectively 7, 
35, and 47 sec after contrast medium injection. TTP was a mean of 41.3 sec. In all the phases of the study the 
lesion was hypoechoic compared with normal surrounding tissue.  
 
 In each dog the contrast study was effectively performed without adverse effects. The 
major difficulties encountered were associated with artefacts due to mineralization, often 
causing distal acoustic shadowing, making imaging of the distal part of the prostate gland 
almost impossible (Fig. 2).    
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Figure. 2: B-mode sagittal (A) and transverse (B) views of a prostatic adenocarcinoma with marked 
mineralization. The distal acoustic shadowing artefacts, make imaging of the distal part of the prostate gland 
very difficult. 
 
 In cases of severe prostatomegaly it was not possible to display the entire gland in the 
field with the 7.5 MHz linear probe, and with the 2.5-3.5 MHz convex transducer there was a 
severe loss of resolution. Another observation was that several, small cyst formations could 
alter the curve value calculations because of non-enhancing areas within the region of interest.   
 For the normal dogs, the PPI was a mean of 16.8 % (+ 5.8 SD) with a median of 17.80 
%. The mean TTP was 33.6 + 6.4 sec with a median of 34 sec. For dogs with benign 
conditions there were no statistical differences (p=0.12) to values for the normal dogs. For 
benign prostatic hyperplasia the PPI was a mean of 16.9 + 3.8 % (median 15.8%) and the TTP 
was a mean of 26.2 + 5.8 sec (median 24.4 sec). For mixed benign pathology the PPI was a 
mean of 14.8 + 7.8% (median 12.2%) and the TTP was a mean of 31.9 + 9.7 sec (median 32.8 
sec); for prostatitis the PPI was 14.2% and the TTP was 25.9 sec. 
 For the 4 dogs with adenocarcinoma, values were significantly higher (p<0.05) than 
the normal dogs; the PPI was a mean of 23.7 + 1.9% (median 24.2%) and the TTP was 26.9 + 
4.8 sec (median 21.1 sec). For the dog with the leiomyosarcoma values were not compared 
statistically but were numerically lower than in the normal dogs; the PPI was 14.1% and the 
TTP was a mean of 41.3 sec.  
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DISCUSSION 
 
 Imaging the prostate gland of dogs with prostatic disease is common within clinical 
veterinary practice. Unfortunately however, there is a lack of specificity of the US 
characteristics of different conditions of the prostate, making their differentiation difficult 
(Mattoon and Nyland, 2002). In the present study we were also unable to demonstrate specific 
US features characteristic of different types of prostatic pathology. Furthermore, even using 
colour Doppler ultrasound it was not possible to distinguish between benign or malignant 
lesions. However, B-mode US was useful in allowing measurement of prostatic dimensions as 
well as the documentation of cystic lesions and para-prostatic changes including the presence 
of peritoneal fluid. 
 Although prostatic pathology in dogs differs to the disease observed in men it is 
worthy of note that in human medicine, transrectal imaging of the prostate using CEUS is a 
well-established technique used in attempt to diagnose cases of neoplasia. Within a large 
study trans-rectal three-dimensional power Doppler using CEUS was found to detect 68-79% 
of all tumour foci larger than 5 mm, leading the authors to conclude that three-dimensional 
power Doppler CEUS was the best single diagnostic tool for the detection of prostatic 
carcinoma (Unal et al., 2000). A recent study also noted that three-dimensional power 
Doppler CEUS had the potential to identify lesions where there was increased micro vessel 
density (Sedelaar et al., 2001), and Goossen et al. (2003) proposed that discrimination 
between left and right sided tumours could be accurately performed in 78% of cases using the 
same technique followed by off-line analysis. Most recently, Wink et al. (2008) documented 
good correlation between histological findings and CEUS in relation to tumour localisation.  
 To our knowledge, this is the first study in veterinary medicine to describe the use of 
CEUS to evaluate prostatic perfusion in dogs with prostatic disease. The study used methods 
that were the same as those investigating normal prostatic perfusion (Russo et al., 2009), 
including a consistent anaesthetic protocol. The prostatic perfusion measurements for dogs 
with normal prostate glands in this study were similar to those previously reported by Russo 
et al. (2009).  
 In the present study, there were no significant differences between prostatic perfusion 
in dogs with benign prostatic pathology compared with the normal dogs. These findings 
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probably relate to the fact that these pathologies are slow to develop and result in limited 
change in parenchymal histology at least over the course of several years. Subjective 
evaluation of the data showed differences amongst the tumours; in dogs with prostatic 
carcinoma, perfusion values were numerically higher than for normal dogs, whilst for the 
single dog with leiomyosarcoma, the perfusion was numerically lower than in normal dogs. 
Clearly, examination of a greater number of dogs is required to further elucidate these very 
preliminary observations. However, these general features are consistent with observations of 
similar tumours affecting other organ systems. For example, hepatic carcinomas demonstrate 
hyperperfusion during wash in, higher PPI than normal tissue, faster TTP, and 
hypoechogenicity during the wash out phase (O‘Brien et al,. 2004), and are normally 
hypervascular, whereas no other lesions show hypervascularity (Kanemoto et al., 2009). Each 
of these features is similar to the 4 prostatic carcinomas described in the present study. 
Furthermore, the leiomyosarcoma detected in the present study has similar features to other 
sarcomas, such as hemangiosarcomas and undifferentiated sarcomas of the spleen, which are 
characterized in all phases by an homogeneous anechoic (non-perfused) area with surrounding 
highly vascularized parenchyma (peripheral irregular perfusion pattern) (Rossi et al., 2008; 
Haers and Saunders, 2009).  
 In the present study dogs were also subjected to biopsy of the prostate gland, taken 
from random areas of the parenchyma unless there was an obvious focal lesion which was 
then targeted. There were no complications in any of the dogs following this procedure. It has 
been reported that further targeted biopsies during CEUS increase the detection rate of human 
prostate cancer. In dogs random biopsies may still be a necessity, because targeted biopsies 
may miss cancers, especially when located in the transition zone. However, like in humans the 
goal for future research should be improved visualization and localization of cancer to make 
random biopsies avoidable (Mitterbeger et al., 2007). CEUS is a relatively non-invasive 
technique, which can be conducted more quickly and less expensively than a single biopsy. 
Biopsy and consequent histo-pathological examination are likely to be more sensitive 
methods for a definitive diagnosis, whilst for the moment data for CEUS is only available for 
the differentiation of benign from malignant conditions.  
 Although the results of the present study are very encouraging, the technique did 
encounter some difficulty especially when there was marked parenchymal mineralization, 
which impeded the visualization of the distal part of the prostate gland. Furthermore, when 
there was significant prostatomegaly it was not possible to display the entire prostate gland in 
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a single field of view. Moreover, if the prostate was very large, there was a different 
brightness of the organ among the near and far field. 
 In conclusion, in the present study, CEUS was superior to B-mode US for the 
diagnosis of prostatic disorders. CEUS showed features that may be promising for its use as a 
diagnostic tool in dogs with prostatic disorders, particularly for differentiating malignant from 
benign diseases. Whether CEUS should be used alone or in combination with other modalities 
needs further clinical investigation on a greater number of cases. 
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CHAPTER 5 
_________________________________________ 
 
GENERAL DISCUSSION 
 
It is a general consensus in the scientific community that a definitive diagnosis of bone 
or soft tissue lesions depends on histopathological evaluation. The success of a biopsy 
procedure depends on several factors, only some of which are controllable (Kreula et al., 
1990a; Kreula et al., 1990b). The needle type is very important for a successful biopsy. There 
is a large variety of needles available for tissue-core biopsy (TCB). Mostly used are the 
spring-loaded needle and the biopsy gun (Hoppe et al., 1986; Parker et al., 1989; Bernardino, 
1990; Nyland et al, 2002a), but manual needles are also used. The use of a manual needle 
requires an assistant to help the operator during the procedure. If an automated needle is used, 
the operator can manipulate the transducer and conduct the biopsy unassisted. The chosen 
system needs to be quite inexpensive and easy to handle for use in multicentered clinical trials 
in various countries (Rotenberg et al., 2004), with the goal of using the device in clinical 
practice for diagnosis and treatment. A biopsy system should be able to produce core 
specimens of good quality, large enough to be used in micro-array research, and so that 
multiple slices (up to 1000) can be obtained from one single core. The tissue dimensions 
should also fit with new research methods such as immunohistochemistry and molecular 
biology. The biopsy method should also be patient-friendly, as the patient is always the first 
partner in any clinical trial. The procedure for biopsy is another essential factor for success. A 
systematic approach applicable to every individual case would be best. Also, the different 
steps of biopsy should be recorded on film so that the tissue specimen entering the device 
comes with certainty from the targeted lesion. In conclusion, safe biopsies are certainly a very 
important factor of oncological research (Rotenberg et al., 2004). Most imaging modalities 
(fluoroscopy, ultrasonography (US), computed tomography (CT) and magnetic resonance 
imaging (MRI) can be suitable for guiding biopsies. A fluoroscopy unit is quite expensive, 
makes use of X-rays and has limited indications for use in the veterinary clinic, compared to 
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US and CT. Magnetic resonance image-guided interventional procedures have been described 
in human medicine. However, the use of expensive, non-ferromagnetic tools is necessary in 
this case, greatly increasing the cost of the procedure (Finn-Bodner and Hathcock, 1993). 
Fluoroscopy and MRI are only indicated for biopsy guidance in veterinary medicine in rare 
cases (Suter and Lord, 1984; Fisher et al., 1997; Kinzel et al., 2003; Kinzel et al., 2005), 
Donker et al., 2007). Because of all these reasons, our research was focused on US and CT 
with the aim to increase the diagnostic accuracy in bone, lung, and abdominal organs. 
 
 In a first study, CT-guided bone TCB or fine-needle aspiration (FNA) was performed 
in 21 dogs and 2 cats. Our results show that percutaneous freehand CT-guided FNA and TCB 
are accurate for the diagnosis of primary or secondary bony lesions in small animals with an 
overall mean accuracy of 95.7% which corresponds to the rate reported in the human 
literature (Puri et al., 2006; Rimondi et al., 2010). The fact that the same biopsy material was 
used in all animals and that all the procedures occurred in the same institution may have 
improved the diagnostic rate. No major complications occurred in this study. This also 
corresponds to human studies where the complication rate reported for musculoskeletal 
biopsies is lower than 1% (Puri et al., 2006; Rimondi et al., 2010). The most frequently 
reported complications are transient paresis for spinal biopsies and bleeding/hematoma for all 
types of biopsy. Bone fracture after biopsy is extremely rare if the procedure is performed 
correctly. We could not assess post-biopsy associated pain because the dogs used for this 
procedure were lame. However, a worsening of the lameness was observed in 2 dogs during 
the first 3 days after biopsy. Technically, there were some difficulties in selecting the correct 
angle for biopsy of the spine, and keeping the animals motionless during the procedure. 
Interestingly, the intravenous injection of iodinated non-ionic contrast medium prior to biopsy 
provided useful information. It allowed targeting of viable tissue and avoidance of large blood 
vessels. The use of CT-guided biopsy for diagnosis of bone-associated lesions should also be 
compared with the use of other imaging modalities that can be used for biopsy (fluoroscopy, 
US). Computed tomography is clearly superior to fluoroscopy because of its higher contrast 
resolution and because it is a cross-sectional imaging technique avoiding tissue 
superimposition. Computed tomography also allows better evaluation of the exact location 
and extent of the lesion compared to fluoroscopy. Ultrasonography and CT are 
complementary methods for diagnosis of bone disorders and can both be used for guidance of 
biopsy of bone disorders (Boroffka et al., 2007). Ultrasonography is less expensive than CT 
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and is the primary modality to be used for FNA or TCB in daily practice. If detailed 
information is needed on the extension of the lesion or if an appropriate window for US-
guidance cannot be found, CT should be performed. Without a doubt, CT should be preferred 
for deeply located lesions (Puri et al., 2006). In general, the diagnostic accuracy of US (78%-
88%) is slightly lower than that of CT (Samii et al., 1999; Britt et al., 2007). Our study 
concluded that CT-guided biopsy of bone-associated lesions in small animals appears to be a 
safe and accurate technique. 
 
 In a second study, we evaluated the use of CT for biopsy of pulmonary lesions. 
Diagnosis of pulmonary lesions solely on basis of anamnesis and physical examination is 
often challenging. Diagnostic imaging is therefore of paramount importance in this field. 
Computed tomography has been showed to be superior to radiography for diagnosis of lung 
diseases and is actually the imaging method having the highest accuracy for diagnosis. 
However, a correct cytohistopathological diagnosis is required for an accurate diagnosis, 
prognostic and therapeutic plan (Withrow et al., 1981; Withrow et al., 1991; Vignoli et al., 
2003; Vignoli et al., 2004). In our study 49 animals (38 dogs and 11 cats of different breed, 
sex and size) underwent freehand CT-guided biopsies of the lung. Forty-four FNA and 12 
TCB were performed. Only a single tissue specimen was taken from each lesion to limit 
possible complications. An accuracy of 79.5% for FNA and 91.7% for TCB for diagnosis 
(overall mean accuracy 82.1%) was obtained. The first article about thoracic CT-guided 
biopsy in veterinary medicine reported that 4 lung biopsies and one cranial mediastinal biopsy 
(a total of 4 FNA/cytology and 3 TCB/histopathology) were all diagnostic (Tidwell and 
Johnson, 1994). Another study reported an accuracy of 65% for FNA and 83% for TCB 
(Zekas and Crawford, 2004). In human medicine, the diagnostic accuracy of the TCB under 
CT guidance is reported as quite high, between 88% (Lucidarne et al., 1998) and 95% 
(Hänninen et al., 2001), with similar results for FNA, 85%. Some complications, 3 mild 
haemorrhages, 11 cases of mild to moderate pneumothorax and one severe pneumothorax 
were observed in our study, but none of these cases required surgical intervention. In human 
medicine, pneumothorax is the most common complication of percutaneous CT-guided lung 
biopsy ranging from 8% to 61% (Saji et al., 2002; Shantaveerappa et al., 2002). In one study 
on 289 patients, it was reported that application of a thoracic drainage was necessary in 14% 
of the cases (Saji et al., 2002). The risk of pneumothorax in patients that are not sedated 
compared to patients under general anesthesia has been shown to be similar (Steil et al., 
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2009). For TCB, general anesthesia is the rule in veterinary medicine where the patient is 
mostly uncooperative and thus the risk of laceration is high. Another reason to anesthetize 
patients for lung biopsy is that most lung and mediastinal masses show a respiration-
dependent movement (Steil et al., 2009). We can conclude that pneumothorax is a quite 
frequent consequence of lung biopsy. However, it is mostly a mild pneumothorax that doesn‘t 
require intervention and even if more severe, it has mostly no long term consequences for the 
patient. Therefore, CT-guided biopsy can be considered a recommendable technique to reach 
a diagnosis in lung disorders. One limitation for TCB in our study was the size of the lesion. 
Because of the excursion of 23 mm of the needle tip, TCB could not be performed in lesions 
smaller than 4cm. Other types of needles having a shorter excursion are available and can be 
chosen depending on the size of the lesion. Because of the presence of air, US is not a 
valuable alternative to CT for lung biopsy except for pleural masses or masses abutting the 
thoracic wall (Sheth et al. 1999; Middleton et al., 2006). In these cases, US shows a success 
rate exceeding 90% and few complications (<5%) and can be considered a valuable 
alternative to CT (Sheth et al., 1999; Middleton et al., 2006). Endoscopic ultrasound-guided 
biopsy is a valuable alternative to CT for biopsy of lung lesions but the material required for 
such procedures is very expensive for a limited number of indications in veterinary medicine 
(Gaschen et al., 2003).  
 
 Ultrasound-guided biopsies of liver, spleen and kidneys are often performed. 
However, the results are sometimes unsatisfactory (De Rycke et al., 1999; Cole et al., 2002). 
Recently, a new biopsy device called ―Spirotome‖ has been developed and successfully used 
for biopsy of breast, lymph node, peritoneum, bone and liver in humans (Janssens et al., 2002; 
Rotenberg et al., 2004; Nasr et al., 2006; Cusumano et al., 2008). Based on these positive 
results, we decided to study TCB of liver, spleen and kidney in animals using this new device. 
The study was divided into 2 different parts: one part on fresh canine organs and one part on 
clinical live patients. The organ study was preferred to a study on cadavers to avoid the effect 
of the skin on the quality of the samples. On fresh canine cadavers, the Spirotome device 
provided samples of liver, spleen and kidney of good diagnostic quality. Moreover, in a 
previous study, the quality of the samples was considered superior to the ones taken with a 
spring-loaded needle of the same size (Barberet et al., 2007). In the clinical cases, all the 
samples taken with a 10 ga Spirotome needle were diagnostic and of high quality. A higher 
degree of fragmentation was observed in samples obtained from liver and spleen compared 
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with these from the kidney. This is because of the friability of these organs compared with the 
kidney. The best biopsy results were obtained from the renal samples. A previous study on 
FNA using normal bovine liver, bovine testis and pig‘s kidney showed difference in reaction 
of these tissues on suction force and needle movement, resulting in differences in sample 
quality (Kreula et al., 1990c). The bovine liver fragmented easier than the pig‘s kidney 
(Kreula et al., 1990c). Interestingly, in our study, the histological quality of the liver samples 
was better in the neoplastic lesions compared to the non-neoplastic ones, while for spleen and 
kidney the results were similar. A possible reason for this is that the normal liver has a scant 
stromal tissue, whilst in some tumours of our series (particularly in the mesenchymals but 
also in the carcinomas) a large amount of supportive fibrovascular stroma was present, 
making the tissue firmer. In the kidney, samples for diagnosis require the presence of at least 
5 glomeruli per section (Mostbeck et al., 1989). In the study on clinical patients, the mean 
value was 4.75 glomeruli per section, with 2 cases showing only neoplastic tissue in the entire 
biopsy. In the cadaver study, the number of glomeruli was more than required with a mean of 
31.85 glomeruli per section. The number of glomeruli in samples of clinical patients depends 
on the disease process and its stage of evolution. Some of the values obtained after analysis of 
biopsied tissues (bile canaliculi, hepatocytes, centrilobular veins and portal tracts for liver; 
white and red pulp from spleen; cortex medulla and glomeruli for kidney) were 
underestimated due to the presence of space-taking lesions such as neoplasia. Hence, the 
evaluation of benign parenchymal diseases alone would show higher values for the above 
criteria. The use of a 10 ga core biopsy needle also explains the positive results obtained in 
this study. Despite the use of a large core biopsy system, no major complication was noted. In 
a few cases there was mild haemorrhage after the procedure. One cat died due to disseminated 
intravascular coagulation but this is unlikely due to the biopsy procedure. Systemic 
haemorrhage was observed and there was only a mild amount of free fluid in the abdomen. A 
study comparing 5 biopsy methods for hepatic biopsy concluded that all methods produced 
only minimal hemorrhage (Vansanjee et al., 2006). Another study using CEUS to evaluate the 
severity of lesions after renal biopsy and the duration of healing process using a 14 ga needle 
showed few complications and a quite fast healing of the kidney following TCB (Haers et al., 
2010). Our study concluded that the Spirotome system is an easy and safe technique for 
abdominal ultrasound-guided biopsies, in particular for neoplastic lesions of the liver. 
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 In the previous studies of this research, only minor complications were observed, 
confirming the rarity of severe or life-threatening complications. However, major 
complications cannot totally be excluded with TCB procedures (Nyland et al., 2002b). We 
observed 3 cases of tumoral seeding in our clinic. Two occurred after freehand FNA of a 
transitional cell carcinoma of the urinary bladder and one occurred after ultrasound-guided 
FNA of a lung adenocarcinoma. All three procedures were performed with a 22 ga needle 
connected to a 5mL syringe. The two cases of transitional cell carcinoma of the urinary 
bladder were under chemotherapeutic treatment. The first dog with urinary bladder neoplasia 
presented 10 months after diagnosis with a 6 cm ulcerated parapenile mass and, the second 
one presented only 3 months after diagnosis with an irregular, ulcerated, 5 cm mass in the 
abdominal wall along the tract where the FNA had been done. Both masses involved 
subcutaneous tissue of the abdominal wall in the area where the FNA was performed. The 
third case, a 12-year-old Persian female cat was presented 2 weeks after percutaneous US-
guided FNA of a lung adenocarcinoma with a mass of 1cm present on the thoracic wall, in the 
area of the puncture. Cytological examination of the mass confirmed a needle tract 
implantation of the lung adenocarcinoma to the thoracic wall.  
Because of the small needle size, complications like organ damage or post-procedure 
haemorrhage are rare with FNA (Leveille et al., 1993). Needle tract implantation of neoplastic 
cells is another complication of FNA that has been reported in humans and in dogs (Nyland et 
al., 2002b). Dissemination by US-guided aspiration of neoplastic cells in the surrounding 
tissue can occur during the retraction of the needle. Nevertheless, tumor autotransplantation 
studies indicate that at least one million cells are necessary for a successful implantation 
(Southam and Brunschwig, 1961). It is known that of this million only a few cells survive the 
local protective mechanisms and the host immune response (Smith, 1981). Moreover, Weiss 
et al. (1988) estimated that only one out of every 100000 - 1000000 neoplastic cells entering 
the circulation could eventually produce metastasis and it has been stated that during FNA the 
number of disseminated tumor cells is usually less than required for successful implantation 
(Glasgow et al., 1988), explaining why needle tract implantation is rarely checked afterward 
(Kosugi et al., 2004). Cell implantation is related to tumour aggressiveness (Sacchini et al., 
1989). In veterinary medicine, the seeding of transitional cell carcinoma of the urinary tract 
(bladder or urethra) has been reported by Nyland et al. (2002b), indicating that this tumour 
type is more prone to seeding than others. To our knowledge, the Persian cat is the first 
reported case of needle tract seeding of a lung adenocarcinoma after FNA in veterinary 
medicine. It could be hypothesized that lung adenocarcinoma in cats can have high propensity 
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to spread to the thoracic wall after FNA. However, in a recent study including 39 cases of CT-
guided FNAB of the lung (in 30 dogs and 9 cats) this complication has not been reported 
(Vignoli et al., 2004). In this Persian cat, the lapse of time between the FNA and the 
development of the chest wall mass was only two weeks. Recently published data in humans 
(Kim et al., 2003) has shown usual recurrence time lapse of 2 to 16 months. This could 
confirm the possibility of high aggressiveness of the lung adenocarcinoma in this cat. In 
humans, it has been assessed that the risk of tumour seeding increases with the size of the 
needle and the number of attempts. To reduce this risk, small diameter needles (22 ga or 
smaller) have been suggested (De May, 2000). Injection of foreign material into the lesion, 
e.g. ethanol, saline solution, contrast medium or local anaesthetics, may promote 
dissemination of cells as it increases the pressure inside the mass (De May, 2000). The best 
way to avoid needle tract implantation is to change the sampling technique if possible. When 
a malignant neoplasia of the urinary tract and prostate is suspected, cytological samples can 
be obtained by urethral catheterisation. This procedure consists of an external manipulation of 
the bladder and urethra while suctioning with a urethral catheter. Ultrasound guidance (Lamb 
et al., 1996) offers the possibility of guiding the tip of the catheter into the lesion. With this 
technique, the chance to obtain a diagnostic result is higher and the obtained sample large 
enough to permit histological examination. In conclusion, even if needle tract implantation 
after FNA is a rare complication with small animals, it has to be taken into account, especially 
if a carcinoma of the urinary tract is suspected.  
 
 The next step in our research was to see if it would be possible to bypass biopsy 
procedures as cytology or histology in specific cases, so as to differentiate between benign 
and malignant disorders. This can be tried by using contrast-enhanced ultrasound (CEUS) to 
view the specific pattern of perfusion of malignant disorders. In veterinary medicine, some 
data about CEUS has been already published, and it has been suggested a useful modality for 
the diagnosis of focal abdominal lesions (O‘Brien et al., 2004; Rossi et al., 2008; Haers and 
Saunders, 2010). As CEUS has been reported useful for the differentiation between human 
prostate cancer and non-malignant conditions (Mitterberger et al., 2007; Wink et al., 2008), 
we decided to study the prostate in normal and in sick dogs. 
Prostatic disease is frequently encountered in small animal practice. The most common 
conditions affecting the canine prostate include benign prostatic hyperplasia, prostatitis, 
prostatic cysts and prostatic neoplasia (Weaver 1981; Smith, 2008). Unfortunately, the 
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diagnosis of malignant prostatic disease is challenging, as benign and malignant lesions may 
initially have a similar appearance, both on clinical and imaging examinations (Mattoon and 
Nyland, 2002; Jemal et al., 2007). One recent study reported that the presence of 
mineralization in the prostate seen on either abdominal radiographs or ultrasound should be 
considered highly suspicious for prostatic neoplasia (Bradbury et al. 2009). Prostatic 
mineralization is considered even more suspicious for neoplasia if the dog is neutered 
(Bradbury et al,. 2009). However, other studies have reported that mineralization also occurs 
in chronic bacterial prostatitis, benign prostatic concretions (calculi), and prostatic abscess 
(Feeney et al., 1987; Burk and Ackerman, 1996). Using CEUS, a bolus of contrast agent is 
injected intravenously (Haers and Saunders, 2009). Then the gland is monitored to measure 
the accumulation or kinetics of the contrast (Haers and Saunders, 2009). The analysis of 
ultrasound contrast agent bolus kinetics yields various time-intensity curve parameters that 
qualitatively describe regional perfusion. Peak perfusion intensity (PPI) is expressed as a 
percentage of background intensity, and the time to reach peak perfusion intensity (TTP) is 
expressed in seconds from the time of injection. These values represent different aspects of 
vascularisation in the region of interest. Ten dogs with no prostatic abnormalities (mean age 
of 2.2 + 0.9 SD years) and 26 dogs with prostatic disease (mean age of 9.3 + 2.3 SD years) 
were included in our study. The prostate was studied on B-mode US and on CEUS, followed 
by US-guided biopsy, considering the histopathological examination as gold standard. A 
prostatic biopsy was successfully performed in each case without adverse effects which 
corresponds to our findings in the previous studies. We observed no significant difference in 
prostatic perfusion between normal dogs and dogs with benign prostatic pathology. These 
findings can be explained by the slow development of benign prostatic pathology that results 
in limited change in parenchymal histology for several years. Subjective evaluation of the 
data showed differences amongst tumors. In dogs with prostatic carcinoma, perfusion values 
were numerically higher than in normal dogs, while for the one dog with leiomyosarcoma, the 
perfusion was numerically lower than in normal dogs. These features are consistent with 
observations of similar tumours affecting other organ systems. For example, hepatic 
carcinomas demonstrate hyperperfusion during wash in, higher PPI than normal tissue, faster 
TTP, and hypoechogenicity during the wash out phase (O‘Brien et al., 2004) and are normally 
hypervascular, whereas no other lesions show hypervascularity (Kanemoto et al. 2009). Each 
of these features is similar to the ones observed on the 4 prostatic carcinomas described in our 
study. Furthermore, the leiomyosarcoma shows features that are similar to other sarcomas, 
such as hemangiosarcomas and undifferentiated sarcomas of the spleen, which are 
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characterized in all phases by a homogeneous anechoic (non-perfused) area with surrounding 
highly vascularized parenchyma (peripheral irregular perfusion pattern) (Rossi et al. 2008; 
Haers and Saunders, 2009). The dogs of this study also underwent biopsy of the prostate 
gland, without any complications. It has been reported that further targeted biopsies during 
CEUS increase the detection rate of human prostate cancer (Mitterbeger et al. 2007). In dogs 
random biopsies may still be a necessity, because targeted biopsies may miss cancer, 
especially when the cancer is located in the transition zone. However, like in humans, the goal 
for future research should be the improved visualization and localization of cancer so as to 
avoid random biopsies (Mitterbeger et al. 2007). The contrast studies were performed without 
adverse effects. The major difficulties encountered were associated with artefacts due to 
mineralization, often causing distal acoustic shadowing, and making imaging of the distal part 
of the prostate gland almost impossible. In cases of severe prostatomegaly it was not possible 
to display the entire gland in the field with the 7.5MHz linear probe, and with the 2.5-3.5MHz 
convex transducer there was a severe loss of resolution. Another observation was that several 
small cyst formations could alter the curve value calculations because of non-enhancing areas 
within the region of interest. In conclusion, CEUS is superior to B-mode US for the diagnosis 
of prostatic disorders and it shows promising features for differentiating benign and malignant 
prostatic diseases. 
 
Advantages of CEUS compared to biopsies are that it is non-invasive, quickly 
conducted, less expensive and in most cases, it does not require general anesthesia or even 
sedation. Additionally in some cases, such as differentiation between benign and malignant 
liver nodules, CEUS is more accurate than TCB of FNA procedures. Disadvantages of CEUS 
are the lack of trust by the clinicians more used to cytopathological results and the quite 
limited veterinary literature on the topic (nearly exclusively on differentiation between benign 
and malignant lesions). Also, actually, CEUS can only be performed on high-tech machines 
and software quantitative analysis is only available on some of these machines. Additionally, 
except for specific disorders, such as liver nodules, histopathological examination is still a 
more accurate diagnostic method. 
 
In conclusion, imaging examinations ends in most cases with a differential diagnosis. 
Imaging-guided biospy procedures, FNA or TCB, are then necessary and they allow to obtain 
a final diagnosis in more than 90% of the cases for bone, lung or abdominal lesions with a 
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low rate (<5%) of, mostly minor, complications. Contrast-enhanced ultrasonography appears 
an interesting alternative for specific indications such as differentiation between benign and 
malignant disorders. However, more research on this technique is needed to determine the 
exact plusvalue and the true indications of CEUS. 
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SUMMARY 
 
 In order to differentiate between malignant and benign conditions and to increase 
diagnostic accuracy, several imaging modalities and interventional procedures are currently 
used in human and veterinary medicine. The most common imaging modalities used for these 
purposes in veterinary medicine are ultrasonography (US) and computed tomography (CT). 
 
 The first chapter reviews the current literature on image-guided interventional 
procedures in dog and cat. It describes advantages and disadvantages of respectively 
fluoroscopy, US, CT and magnetic resonance imaging (MRI) as a tool for biopsy guidance. 
Fluoroscopy and MRI are less in use as they are less available, irradiating (fluoroscopy) and 
more expensive (MRI) than US and CT. Ultrasonography is still the most common imaging 
modality for biopsy-guidance in veterinary medicine and can be practised on practically the 
entire body. However, CT-guided biopsy has become more popular as CT units have become 
more available on the veterinary market. CT-guided biopsy is considered especially useful for 
bone and lung biopsies, particularly in case of deep-lying lung lesions. 
 
 The second chapter lists the scientific aims. The first two aims of this study are firstly 
the description of the technique of CT-guided biopsy for diagnosis of skeletal disorders and 
secondly its use for diagnosis of lung disorders. The third aim is the evaluation of a new 
biopsy device for the biopsy of abdominal organs, called ―Spirotome‖. The fourth aim is the 
documentation of a specific biopsy procedure complication, namely the implantation of 
tumoral cells along the biopsy needle tract. The fifth and last aim is the development and 
evaluation of a new imaging modality for differentiation of malignant and benign disorders: 
contrast-enhanced ultrasonography. 
 
 The third chapter describes and evaluates the freehand CT-guided biopsy technique for 
skeletal lesions. Twenty-one dogs and 2 cats showing bone lesions upon imaging 
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examination, undergo a CT-guided tissue-core biopsy (TCB: 17 animals) or a CT-guided fine 
needle aspiration (FNA: 6 animals). All 17 TCB samples obtained are diagnostic (100% 
accurate) and so are 5 out of the 6 FNA samples (83.3% accurate). The overall accuracy is 
95.7%. Fourteen neoplastic, 2 infectious and 6 benign lesions are diagnosed. One aspirate 
contains only blood on cytological examination. No major complications are found. The 
intravenous injection of contrast medium prior to biopsy helps with the biopsy guidance as it 
provides valuable information about what blood vessels to avoid and what viable tissue to 
biopsy. Freehand CT-guided TCB and FNA appear to be safe and accurate procedures in 
order to obtain a diagnosis in bone-associated disorders in dogs and cats. 
 
 In the fourth chapter, CT-guided FNA and TCB are evaluated for the diagnosis of lung 
lesions in dog and cat. It is often challenging to reach a diagnosis of pulmonary lesions 
exclusively based on the history and physical examination. In our study, 38 dogs and 11 cats 
of different sex, breed and size undergo either CT-guided lung FNA, TCB, or both. Clinical 
examination, haematology and chest radiography are done on all animals. In this study, 46 
samples out of 56 are diagnostic (82.14%): 35 out of 44 FNA (79,5%) and 11 out of 12 TCB 
(91,7%). Ten cases are considered non-diagnostic, either because of inconclusive diagnosis or 
because only blood is aspirated. Sixteen out of 49 cases show minor complications (32.6%): a 
pneumothorax in 13 cases and a mild haemorrhage in 3 cases. No major complications are 
found. CT-guided biopsy for lung disorders appears safe and shows a good diagnostic value. 
 
 The fifth chapter evaluates the manual biopsy device ―Spirotome‖ on fresh canine 
organs (liver, spleen and kidneys) and on clinical patients in a clinical first experience. In the 
first part of this study 60 biopsies are performed on normal fresh canine organs (20 liver, 20 
spleen, 20 kidney). All the biopsy samples are satisfactory. In the second part, on clinical 
patients, a total of 105 biopsies are executed on 35 lesions in 28 animals (25 dogs and 3 cats). 
All these biopsies are performed in less than 10 minutes and all specimens are diagnostic. The 
histological quality of the liver samples of neoplastic tissue proves superior compared to the 
non-neoplastic ones. This is contrary to the spleen and kidneys results, where the quality is 
similar. The high quality of the samples can be explained by the fact that a 10 ga needle is 
used. Interestingly, this quite large diameter doesn‘t lead to an increased number of 
complications. The use of the ―Spirotome‖ for the biopsy of liver, spleen and kidneys appears 
to be an accurate and safe technique.  
Summary 
161 
 
 The sixth chapter describes needle tract implantation of transitional cell carcinoma of 
the urinary bladder after FNA in 2 dogs and adenocarcinoma of the lung after FNA in 1 cat. 
All 3 masses grow up along the needle tract and can be viewed by US. This is the first 
description of the seeding of pulmonary adenocarcinoma cells on the thoracic wall after FNA. 
 
 The seventh chapter describes the assessment of contrast-enhanced ultrasound (CEUS) 
for the diagnosis of prostatic disease in dogs. Vascular perfusion is assessed in 10 dogs 
without prostatic abnormalities and 26 dogs with prostatic disease using CEUS. The time to 
reach peak contrast intensity (TTP) and peak perfusion intensity (PPI) are measured and 
histological biopsies are collected from each dog. In normal dogs, the mean PPI is 16.8 % + 
5.8 SD and the mean TTP 33.6 + 6.4 sec SD. Benign conditions are not statistically different 
from normal dogs (p>0.05): for benign prostatic hyperplasia the mean PPI is 16.9 + 3.8 % SD 
and the mean TTP 26.2 + 5.8 sec SD; for mixed benign pathology the mean PPI is 14.8 + 
7.8% SD and the mean TTP 31.9 + 9.7 sec SD; for prostatitis the mean PPI is 14.2% and the 
mean TTP 25.9 sec. Malignant conditions have perfusion values that differ from normal dogs 
(p<0.05), although evaluation of the data for individual malignancies doesn‘t prove 
consistent: for adenocarcinomas the PPI is higher with a mean of 23.7 + 1.9% SD and a mean 
TTP of 26.9 + 4.8 sec SD, while for the dog with leiomyosarcoma values are lower with a 
mean PPI of 14.1% and mean TTP of 41.3 sec. Contrast-enhanced ultrasound shows 
differences in perfusion between malignant and benign lesions. Studies on a larger number of 
animals are required to confirm these results. 
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SAMENVATTING 
 
 Om kwaadaardige en goedaardige processen te kunnen differentiëren en om de 
diagnostische accuraatheid te verbeteren, worden vandaag de dag verscheidene 
beeldvormingsmodaliteiten en interventionele procedures toegepast, zowel in de humane als 
in de diergeneeskunde. De meest gebruikte beeldvormingsmodaliteiten in de diergeneeskunde 
zijn echografie (US) en computer tomografie (CT).  
 
 Het eerste hoofdstuk geeft een overzicht van de huidige literatuur over interventionele 
procedures met beeldbegeleiding bij hond en kat. Erin worden de voor- en nadelen van 
fluoroscopie, US, CT en magnetische resonantie (MRI) als beeldvormende hulpmiddelen bij 
biopsie beschreven.  
Fluoroscopie en MRI worden minder gebruikt aangezien deze modaliteiten minder 
beschikbaar zijn, stralingsgevaar inhouden en duurder uitvallen dan US en CT. Echografie 
blijft de meest gebruikte modaliteit voor beeldbegeleiding van biopsie in de diergeneeskunde 
en kan gebruikt worden bij praktisch alle zones van het lichaam. Toch komt CT-begeleiding 
steeds meer voor, en dit omwille van de grotere beschikbaarheid van CT units. CT-
begeleiding haalt vooral goede resultaten bij bot- en longbiopsieën, in het bijzonder bij diep 
gelegen longletsels.  
 
 In het tweede hoofdstuk worden de wetenschappelijke doelstellingen geformuleerd. 
De eerste twee doelstellingen van de studie zijn: ten eerste het beschrijven van de techniek en 
ten tweede de evaluatie van biopsieën onder CT-begeleiding met het oog op de diagnose van 
skelet- en longaandoeningen. De derde doelstelling is de evaluatie van een nieuwe 
biopsienaald, de spirotome of spirotoombiopsienaald of spirotoomnaald, specifiek voor de 
biopsie van abdominale organen. De vierde doelstelling is het beschrijven van een 
welbepaalde biopsiecomplicatie, namelijk het overbrengen of uitzaaien van tumorale cellen 
via de holle buis van de biopsienaald. De vijfde en laatste doelstelling is de ontwikkeling en 
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evaluatie van de nieuwe modaliteit contrastechografie gericht op de differentiatie tussen 
kwaadaardige en goedaardige aandoeningen.  
 
 Het derde hoofdstuk beschrijft en evalueert de techniek vereist bij vrije hand CT-
begeleide biopsie van skelettale aandoeningen. Eénentwintig honden en twee katten met 
botletsels ondergaan hierbij een weefselkernbiopsie (TCB, 17 dieren) of een dunne 
naaldaspiratie (FNA, 6 dieren), telkens onder CT-begeleiding. Al de TCB-stalen (100% 
accuraat) en 5 van de 6 FNA-stalen (83,3% accuraat) zijn diagnostisch. De algehele 
accuraatheid bedraagt 95,7%. Veertien neoplastische, 2 infectieuze en 6 goedaardige letsels 
worden vastgesteld. Eén aspiratiestaal bevat enkel bloed op het cytologisch onderzoek. Geen 
grote afwijkingen worden vastgesteld. De intraveneuze injectie van een contrastmedium 
voorafgaand aan de biopsie geeft bruikbare informatie over te vermijden bloedvaten en het te 
biopteren weefselgedeelte. Vrije hand CT-begeleide CTB en FNA blijken veilige en accurate 
diagnostische procedures voor botletsels bij hond en kat.  
 
 In het vierde hoofdstuk wordt een evaluatie gemaakt van CT-begeleide CBT en FNA 
ter diagnosticering van longletsels bij hond en kat. De diagnose van pulmonaire letsels is vaak 
zeer moeilijk indien men zich enkel baseert op anamnese en klinisch onderzoek. 
Beeldvorming kan daarbij een zeer belangrijk diagnostisch hulpmiddel zijn, en met name de 
biopsie. In deze studie ondergaan 38 honden en 11 katten - van beide geslachten, 
verschillende rassen en groottes - een CT-begeleide FNA of CBT of beide. Een klinisch en 
hematologisch onderzoek en een thoraxradiografie worden op al deze dieren uitgevoerd. In 
deze studie blijken 46 van de 56 stalen diagnostisch (82,14%): 35 van de 44 FNA‘s (79,5%) 
en 11 van de 12 TCB‘s (91,7%). Tien stalen zijn niet diagnostisch, ofwel omdat ze 
onduidelijk zijn ofwel omdat enkel bloed werd geaspireerd. Zestien van de 49 stalen tonen 
milde afwijkingen (32,6%): pneumothorax bij 13 stalen en milde hemorragie bij 3 stalen. 
Geen grote afwijkingen worden vastgesteld. CT-begeleide biopsie voor longaandoeningen 
blijkt een veilige methode met een grote diagnostische waarde.  
 
 In het vijfde hoofdstuk wordt de spirotoombiopsienaald geëvalueerd op verse 
hondenorganen (lever, pancreas en nieren) en op klinische patiënten in een eerste klinisch 
experiment. De studie wordt opgedeeld in 2 verschillende delen. In het eerste deel worden 60 
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biopsieën uitgevoerd op normale hondenorganen (20 op de lever, 20 op de pancreas en 20 op 
de nieren). Alle biopsiestalen blijken van voldoende kwaliteit. In het tweede 
onderzoeksgedeelte, op klinische patiënten, worden in totaal 105 biopsieën uitgevoerd op 28 
dieren (25 honden en 3 katten). Al deze biopsiën worden uitgevoerd in minder dan 10 
minuten en alle stalen blijken diagnostisch. De histologische kwaliteit van de stalen 
neoplastisch leverweefsel is beter dan die van de stalen niet-neoplastisch leverweefsel. Dit is 
niet het geval bij de pancreas en de nieren waar geen verschil in kwaliteit kan vastgesteld 
worden. De hoge kwaliteit van de stalen kan verklaard worden door het gebruik van een 10 ga 
naald. Opvallend genoeg resulteerde dit gebruik van een dikkere naald niet in een toename 
van het aantal complicaties. Het gebruik van de spirotoomnaald voor de biopsie van lever, 
pancreas en nieren blijkt een beloftevolle techniek die accuraat en veilig is.  
 
 Het zesde hoofdstuk beschrijft de uitzaaiïng van transitionele 
urineblaascarcinomacellen bij 2 honden en longadenomacarcinoma cellen bij één kat na fijne 
naaldaspiratie. De 3 massa‘s breiden uit via de naaldweg en kunnen gevisualiseerd worden 
met behulp van US. Het is de eerste keer dat een uitzaaiïng van longadenomacarcinome cellen 
op de thoraxwand na een fijne naaldaspiratie beschreven wordt.  
 
 Het zevende hoofdstuk beschrijft de evaluatie van vaatdoorbloeding ‗kinetics‘ met 
behulp van contrastechografie (CEUS) voor de diagnose van prostaatziekten bij de hond. De 
vaatdoorbloeding wordt bekeken bij 10 honden zonder prostaatafwijkingen en bij 26 honden 
met een prostaatziekte, met behulp van CEUS. De tijd die nodig is om de piek in 
contrastintensiteit (TTP) en de piek in de doorbloedingsintensiteit (PPI) te bereiken, wordt 
gemeten. Histologische biopsieën worden uitgevoerd bij elke hond. Bij normale honden is de 
gemiddelde PPI 16,8% (met een standaarddeviatie van 5,8%) en de gemiddelde TTP 33,6 sec 
(standaarddeviatie 6,4 sec). Niet-kwaadaardige aandoeningen differentiëren statistisch gezien 
niet van normale honden (p>0.05); voor goedaardige prostaathyperplasie is de gemiddelde 
PPI 16,9% met een standaarddeviatie van 3,8% en de gemiddelde TTP 26,2 sec met een 
standaarddeviatie van 5,8 sec; voor een gemengde goedaardige aandoening is de gemiddelde 
PPI 14,8% met 7,8% standaarddeviatie en de gemiddelde TTP 31,9 sec met 9,7 sec 
standaarddeviatie; voor prostatitis tenslotte is de gemiddelde PPI 14,2% en de gemiddelde 
TTP 25,9 sec.  
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Kwaadaardige aandoeningen hebben doorbloedingswaarden die differentiëren van die bij 
normale honden (p<0.05), hoewel een evaluatie van de gegevens van individuele 
aandoeningen geen consistente trend vertoont: voor adenocarcinomen is de PPI numeriek 
hoger met een gemiddelde van 23,7% (1,9% standaarddeviatie) en een gemiddelde TTP van 
26,9 sec (standaarddeviatie 4,8 sec), terwijl voor leiomyosarcomen de waarden numeriek 
lager liggen met een gemiddelde PPI van 14,1% en een gemiddelde TTP van 41,3 sec. 
Contrastechografie brengt dus verschillen in doorbloeding aan het licht die kunnen 
differentiëren voor kwaadaardige en niet-kwaadaardige letsels. Een studie op een groter aantal 
dieren is vereist om deze resultaten te bevestigen.  
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